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ABSTRACT OF THE DISSERTATION 
RATE KINETICS AND MOLECULAR DYNAMICS OF THE STRUCTURAL 
TRANSITIONS IN AMYLOIDOGENIC PROTEINS 
by 
Timothy M. Steckmann 
Florida International University, 2016 
Miami, Florida 
Professor Bernard S. Gerstman, Co-major Professor 
Professor Prem P. Chapagain, Co-major Professor 
Amyloid fibril aggregation is associated with several horrific diseases such as 
Alzheimer’s, Creutzfeld-Jacob, diabetes, Parkinson’s and others. The process of 
amyloid aggregation involves forming myriad different metastable intermediate 
aggregates. Amyloid fibrils are composed of proteins that originate in an innocuous α-
helix or random-coil structure. The α-helices convert their structure to β-strands that 
aggregate into β-sheets, and then into protofibrils, and ultimately into fully formed 
amyloid fibrils. On the basis of experimental data, I have developed a mathematical 
model for the kinetics of the reaction pathways and determined rate parameters for 
peptide secondary structural conversion and aggregation during the entire 
fibrillogenesis process from random coil to fibrils, including the molecular species that 
accelerate the conversions. The specific steps of the model and the rate constants that 
are determined by fitting to experimental data provide insight on the molecular species 
involved in the fibril formation process. To better understand the molecular basis of the 
protein structural transitions and aggregation, I report on molecular dynamics (MD) 
 vi 
computational studies on the formation of amyloid protofibrillar structures in the small 
model protein ccβ, which undergoes many of the structural transitions of the larger, 
naturally occurring amyloid forming proteins. Two different structural transition 
processes involving hydrogen bonds are observed for aggregation into fibrils: the 
breaking of intrachain hydrogen bonds to allow β-hairpin proteins to straighten, and the 
subsequent formation of interchain hydrogen bonds during aggregation into amyloid 
fibrils. For my MD simulations, I found that the temperature dependence of these two 
different structural transition processes results in the existence of a temperature window 
that the ccβ protein experiences during the process of forming protofibrillar structures. 
Both the mathematical modeling of the kinetics and the MD simulations show that 
molecular structural heterogeneity is a major factor in the process. The MD simulations 
also show that intrachain and interchain hydrogen bonds breaking and forming is 
strongly correlated to the process of amyloid formation. 
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1. INTRODUCTION 
Amyloid fibrils are protein structures that are associated with many debilitating 
human diseases such as Alzheimer’s(AD), Parkinson’s, Creutzfeldt-Jakob and diabetes, 
and in animal diseases such as BSE.  
 Amyloid fibrils are composed of proteins that originate in an innocuous α-helix or 
random coil structure. The proteins convert their structure to β-strands that aggregate 
into β-sheets, and then into protofibrils, and ultimately into fully formed amyloid fibrils 
that are composed of about 600 protein chains. Although humans have evolved 
defenses against aggregation,1 unfortunately amyloid aggregation still occurs in 
humans. Pre-fibrillar β-aggregate structures have been found to be highly neurotoxic, 
and are more neurotoxic than mature amyloid fibrils or amyloid plaques.2,3,4 It remains 
uncertain which of the specific aggregates (protofibrils, protofilaments, or small 
oligomers) is most dangerous.5,6,7,8 A detailed molecular-level understanding of the 
formation process of amyloid fibrils is crucial for determining the molecular species 
that are toxic and for developing methods to slow down or prevent these horrific 
diseases.    
Research on amyloid fibril formation overlaps strongly with prion related 
diseases.9 It also has potential nanoscience and material engineering applications since 
amyloid fibrils are especially strong mechanically.10,11 
 
1.1 What Is Already Known About the Fibrillization Process 
Amyloid fibrillation is a type of protein aggregation. Small β-aggregates form 
protofilaments which are composed of β-sheets parallel to each other. These 
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protofilaments then wrap around each other like strands of rope to make protofibrils. 
Protofibrils grow to form fibrils, which are insoluble. All fibrils have rope-like, twisted 
structures that reflect that they are assembled from filamentous structures. Fibrils can 
grow either by attaching of single monomers or attaching of β-aggregates. Figure 1.1 
shows schematics of a single β-sheet, a protofilament, a protofibril and a fibril. 
 
 
Fig. 1.1 Structure schematics. Schematic of a single β-sheet was done using Pymol. 
Pictures of a protofilament, a protofibril, and a fibril were done using PowerPoint 
following a diagram by David Talaga.12 
 
Experimentalists have created amyloid fibrils in vitro. Solid state NMR 
measurements have shown the general structure of fibrils. However, detailed 
information about the kinetics of the fibrillization process is incomplete.  
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Unfortunately, in vivo experiments are hard to perform and yield only the concentration 
of fibrils, but not the concentration of the precursors. In vitro studies allow 
measurements of the concentrations of some structural stages but the aggregation 
kinetics are unclear since the experimental techniques do not allow a distinction 
between individual intermediate β-structures. Likewise, detailed information about the 
molecular dynamics of various stages is also incomplete. Some information is available 
but details on a molecular level are experimentally difficult to obtain because it is hard 
to crystallize various β precursor structures such as protofibrils.  
Slight variations in experimental preparation procedures such as purification 
and synthesis may significantly change the peptide system’s fibrillogenic properties. An 
additional complication is that a single system of proteins of the same species tends to 
have a heterogeneous combination of aggregates. One common observation is that 
increases in concentration of proteins tend to speed up aggregation.13,14,15 
 Several processes of protein aggregation often happen concomitantly with 
amyloid formation. Some of these processes create amorphous aggregates.16   Although 
amorphous aggregates are associated with misfolding diseases, some amorphous 
aggregates never form into amyloids. Some aggregates are small soluble oligomers, 
which can be swept out by the body.16   
 
1.2 Free Energy 
  The idea for using free energy landscapes to describe different states in the 
fibrillation process came from protein folding.11 The free energy is a complicated 
landscape in amyloid formation since amyloid formation involves both protein folding 
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and several proteins interacting with each other.11 However, useful information can still 
be obtained from free energy landscapes of amyloids and their precursors. An example 
of a free energy landscape to describe the aggregation process is given in Fig. 1.2. It is 
taken from Figure 8.2c of Amyloid Fibrils and Prefibrillar Aggregates.11 Amyloid 
fibrils in Fig. 1.2 clearly correspond to the lowest free energy minima.          
 
 
Fig. 1.2. Free energy landscape example.  
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1.3 Hydrogen Bonds and Aggregation 
Any protein can undergo amyloid aggregation,17 which may be because the 
formation and stabilization of β-sheets involves interchain hydrogen bonds between 
protein backbones17 which are common to all amino acids. Different hydrogen bonding 
patterns between backbones correspond to the different stages in the 
folding/aggregation process.    
Simulation of two short Aβ(16-22) peptides by Santini et al.18 showed multiple 
complex routes to fibrillization involving various networks of hydrogen bonds. 
Conformational properties of amyloids and their precursors can be partially described 
by the number of interchain and intrachain hydrogen bonds. There are many intrachain 
hydrogen bonds when a protein is in an α-helical secondary structure or a hairpin 
conformation, whereas there are many interchain hydrogen bonds among proteins when 
they are in a β-sheet. Interchain hydrogen bonds form cooperatively with other 
interchain hydrogen bonds in the aggregation process.     
 
1.4 Stages in the Fibrillization Process 
 
1.4.1 Nucleation and Secondary Structure 
 According to classical nucleation theory, a nucleus is an aggregate of several 
proteins. It is the smallest aggregate size for which the rate of association is higher than 
the rate of disassociation. Once the nucleus is formed, the aggregation becomes a 
downhill polymerization process. What typically happens is, by chance, a group of 
proteins stick together with a number of proteins large enough that the energy loss is 
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greater than the entropy loss due to another protein joining the aggregate. Although 
classical nucleation theory talks about a nucleus as being made up of several proteins, a 
nucleus can be as small as a single protein (as in the case of transthyretin).19 It could 
even be made up of a few residues of a protein. 
 The typical aggregation process involves some α-helices or proteins that have 
some regions of α-helix in them that eventually convert to β-strands as the aggregates 
undergo reorganization. In an article written by Lomakin et al.2 the proteins come 
together to form micelles, which are loosely-bound disordered aggregates. These 
micelles then break apart into nuclei, as described in my article20 and described later in 
Chapter 3. The initial assembly of proteins is like a micelle. The micelle or micelle-like 
aggregate breaks up into single proteins or small aggregates mostly in the β-strand 
state.20 The process from single proteins to β-sheet is described as a “nucleated 
conformational conversion” by Cheon et al.21       
 
1.4.2 Steric Zipper 
 The steric zipper conformation helps to stabilize amyloid fibrils. A steric zipper is 
a pair of parallel β-sheets. β sheets come together due to the hydrophobic force and 
their side chains interlock. Their van der Waals forces hold them together. The steric 
zipper has no water molecules between the two β-sheets, causing it to be a dry 
interface.22,23,24,11 Two different steric zippers can join through a wet interface.24 A wet 
interface has water and many hydrogen bonds between the side chains. The steric 
zipper is a common configuration of the protofilament.25 Some protofilaments contain 
only one steric zipper whereas some contain several.      
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1.4.3 Hairpin Straightening 
 Hairpins are stabilized by intrachain hydrogen bonds and hydrophobicity. For 
general amyloid proteins, the intermediate aggregates are partly composed of β-strands 
in the hairpin state and/or ones that are extended. The oligomers tend to have a higher 
percentage of β-strands in the hairpin state than the fibrils. The book Molecular 
Modeling at the Atomic Scale by Zhou26 explains that the hairpin tends to serve as the 
growing end of the sheet. However, hairpins at the edges of oligomers tend to impede 
other proteins joining the aggregate. These hairpins needs to straighten out before 
bonding to other proteins. Zhou explains that hairpins can straighten out becaue of 
electrostatic forces.26 Many have suggested that key nucleation steps in the amyloid 
fibril formation process involve β-hairpin conformations.    
 
1.5 Temperature 
 Increases in temperature have the effect of speeding up the aggregation process.27 
Hairpins can also straighten out when exposed to high temperature and not interacting 
with other proteins. High temperature causes the protein not interacting with other 
proteins to be entropy-driven and remain highly flexible in random-coil configurations, 
rather than trying to lower its energy by intrachain hydrogen bonds. If the temperature 
is high enough, the aggregation process may not involve any α-helices and instead just 
β-strands and random coils.    
It has been suggested that most proteins have segments capable of forming 
amyloid fibrils if flexible enough, but most proteins have evolved to effectively conceal 
these segments.1 Although only certain proteins undergo aggregation in vivo, almost 
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any globular protein can be made to form amyloid aggregates by denaturing it with heat 
or chemicals.1 
 
1.6 Heterogeneity 
 It is hard to overstate the heterogeneity of amyloid precursors. Simulation of two 
short Aβ(16-22) peptides by Santini et al.18 showed significant heterogeneity in forming 
a dimer. The heterogeneity of much larger amyloid forming systems is likely to have 
significantly more heterogeneity than the system of Aβ(16-22) peptides by Santini et 
al.18 Amyloid precursors can potentially assume many conformations that are 
structurally distinct.11, 20, 28,29 No structure element common to all oligomers has been 
found. Some aggregates have parallel β-sheets and some have antiparallel β-sheets.30 
Some aggregates have both parallel and antiparallel β-sheets. Oligomers tend to have 
different numbers of proteins.  
 Another cause of heterogeneity is that for an aggregating system, many of the 
proteins may be undergoing secondary structure conversions.11 Although α-helices are 
not a main constituent of the ordered fibril structure, there can be α-helices in the 
intermediate aggregates. There is also a significant amount of heterogeneity in the 
fibrils. For instance, fibrils can be composed of both anti-parallel and parallel β-sheets. 
They also can have different β-sheet registries. 31 
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1.7 Work Performed on Amyloid-Like Fibrillization 
 
1.7.1  Mathematical Modeling of Real Aβ  Proteins to Gain Insight into Various 
Steps 
 An extensively studied, naturally occurring peptide system is the amyloid beta 
precursor Aβ peptide, which is responsible for amyloid deposits in AD.   Naturally 
occurring Aβ peptides have a length in the range of 39–43 amino acids.   Experiments 
have elucidated valuable structural information of variants such as Aβ(10-35), Aβ (1-
40) and Aβ (1-42) peptides. Fibrillar structures are formed when Aβ acquires a β 
secondary structure. Though the molecular mechanisms of fibrillation are still 
uncertain, it is known that Aβ fibril formation is a multi-step nucleated polymerization 
process that involves soluble oligomeric intermediates called protofibrils.30     
Many different theoretical models have been created for the rates of the 
processes of aggregation.32,33,34,35 These models, however, are unable to explicitly deal 
with the fact that amyloid precursors are heterogeneous. 
Kinetic models that include reaction pathways and rate parameters for the 
various stages of the process can be helpful toward understanding the dynamics on a 
molecular level. Rates for peptide structural transformations that nucleate β-structure, 
as well as rates for aggregation/polymerization into fibrils are especially interesting. 
There are experimental data on rate parameters for some of the stages of the fibril 
formation process. The stages that have experimental data can have protein specifics be 
accurately measured. These include the investigations on the elongation and nucleation 
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rate parameters for fibrillogenesis at low pH, rates of nuclei production and association, 
and lag time and rate of aggregation. Experiments have shed light on aspects of the 
process of Aβ aggregation from random coil to fibril. Kirkitadze et al.28 were able to 
measure the temporal changes of concentrations of different types of secondary 
structures: random coil, α-helix, β-strand/sheet, and β-turn for both Aβ(1-40) and 
Aβ(1-42). These measurements were done over a period of 20 days for Aβ(1-40) and 
10 days for Aβ(1-42), allowing enough time for fibrillogenesis to occur. Fezoui and 
Teplow36 measured the concentration of prefibrillar and fibrillar β-structure as a 
function of time in different solvent conditions. Walsh et al. 37 measured the 
concentration of various secondary structures as a function of time during the 
aggregation process.    
On the basis of the experimental data, I have developed a mathematical model 
to determine viable reaction pathways and rate parameters for peptide secondary 
structural conversion and aggregation during the entire fibrillogenesis process from 
random coil to fibrils, including the species that accelerates the conversions. The 
numerical solutions yield graphs of concentrations of different molecular species versus 
time. With the proper choice of transition rate parameters, my model is able to nicely fit 
the time dependence of the concentrations measured experimentally by Kirkitadze et 
al.,28 Walsh et al.,37 and Fezoui and Teplow.36 The model and the rate constants include 
different molecular structural stages in the nucleation and polymerization process and 
provide insight on the molecular species involved in the fibril formation process. 
Determination of rate parameters for the various peptide structural conversion 
steps during fibril formation may be helpful in developing efficacious therapies for AD.  
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1.7.2 Ccβ  Molecular Dynamics Computer Simulations to Uncover Molecular 
Level Details  
Molecular dynamics (MD) computer simulations provide insight into the 
molecular details of various steps, such as the rearrangement of hydrogen 
bonds. I simulated a system with 12 ccβ proteins. 38,39,40,41,42,43 ccβ is a de novo 
protein that is naturally in coiled-coil trimers at low temperatures but transitions 
to amyloid fibrils at high temperatures. I used Replica Exchange Molecular 
Dynamics (REMD) to model the aggregation process of ccβ. REMD makes it so 
that the system being simulated climbs over energy barriers in much shorter 
times than in constant temperature MD. The temperatures I used were in a range 
of 380 - 600K.    
I observed ccβ developing protofilaments with extended β-strands, 
corroborating what was found by Strodel et al.40 From these MD computational 
studies, I was able to investigate changes in the hydrogen bond arrangements 
and calculate thermodynamic properties that characterize the temperature 
dependence of the structural transitions.  
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2. METHODS 
The association of fibrillar Aβ with AD has stimulated interest in the kinetics 
and dynamics of Aβ fibril formation. Fibrillar Aβ is a fibril-like structure composed of 
many Aβ proteins. The Aβ proteins have 39 to 43 amino acids. They are produced by 
cleavage from a larger precursor protein, APP.  
I used two different theoretical and computational approaches for studying 
fibrillization. In order to investigate the kinetics of the different oligomerization stages, 
I developed a system of coupled, non-linear differential equations describing the time 
evolution of the population of the different oligomer species. My model incorporated 
the heterogeneity of the oligomers. To study the molecular dynamics, I used a 
computational approach. It is very difficult to gain from experiments a detailed 
description of small oligomer formation, because of the structural heterogeneity and 
transient nature of the small oligomers. In order to investigate the molecular details of 
the fibrillation process, I used MD computer simulations. 
 
2.1 Mathematical Modeling of Oligomer Population Kinetics 
 The important issues that must be incorporated into a mathematical model of the 
kinetics of the fibrillization process are the many different stages of oligomerization, as 
well as the heterogeneity within some of the stages. Compartmental modeling is an 
important concept for the development of a good model. 
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2.1.1 Introduction to Compartmental Modeling 
 Many people are familiar with compartmental analysis from radioactive decay. 
The R compartment is the number of radioactive atoms that have not yet decayed. The 
D compartment is the number of atoms that have decayed. The system is homogenous, 
with each radioactive atom having an identical rate constant k of decay. Figure 2.1 
shows the radioactive decay scheme. 
 
Fig. 2.1 Radioactive decay schematic. 
 
The rate constant k has the units of 1/time (sec-1) and 1/k≡τ gives the characteristic time 
for decay of R. If the system is homogenous, the D compartment follows a simple 
exponential with time, eq. (2.4). Assuming at time t=0, [R]=[R0] and [D]=0 ! !!" = −𝑘 𝑅   (2.1) 
→ 𝑑 𝑅′𝑅′ = −𝑘𝑑𝑡! → 𝑑 𝑅!𝑅! = −𝑘 𝑑𝑡!!! →
!
!! 𝑙𝑛 𝑅𝑅! = −𝑘𝑡 
è 𝑅 = [𝑅!]𝑒!!"  (2.2) ! !!" = 𝑘 𝑅 = 𝑘 𝑅! 𝑒!!"    (2.3) 
→ 𝑑 𝐷!![!!]!! = 𝑘 𝑅! 𝑒!!!!𝑑𝑡!!!!!! → 𝐷 = − 𝑅! 𝑒!!" − 1  
è 𝐷 = 𝑅! 1− 𝑒!!"             (2.4) 
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The starting equation (2.1) has a simple form because each radioactive atom had the 
same rate constant of decay, k. This led to a simple exponential function, equation (2.4) 
with respect to time for the growth of compartment D. 
 Now, let us consider a transition process in general, as shown in Figure 2.2. 
 
Fig. 2.2 Generalized schematic for transitions between two species. Species A may have 
heterogeneity gk in the rate constant for transitions to B. 
 
 Using a simple equation like (2.1), ![!]!" = −𝑘[𝐴] would give a simple exponential 
for the population of compartment B, similar to equation (2.4) for radioactive decay. 
However, if each entity in A has a different rate constant, equation (2.1) and the 
resulting equation (2.4) for the time-dependence of the population are no longer valid. 
The heterogeneity in k can be expressed as  
     ! !!" = − 𝑔!𝑘 𝐴 𝑑𝑘!    (2.5)  
where gk is the fraction of A molecules with a specific value for the rate constant k, and 
the integral is over all possible values of k. If we substitute equation (2.5) for (2.1) 
above, the derivation leading to (2.4) becomes much more complicated than if we had 
used (2.1). Analytical solutions are not possible except for very special probability 
distributions of gk. Especially important for the present work and for most systems, the 
distribution function gk of the molecular components is usually not known, and 
therefore it is not possible to include gk in the analysis. Fortunately, there is a way to 
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create a mathematical model that allows the investigation of the kinetics of the different 
species that are known to transition amongst each other.   
 Mathematical modeling of heterogeneous kinetics can be performed without 
knowledge of gk if we substitute for the heterogeneity gk in the rate constant of one step 
by inserting several fictitious steps using fictitious sub-compartments. The population 
of each fictitious sub-compartment is treated as being homogeneous and therefore each 
transition from one compartment to the next can be described by a single rate constant, 
as shown in Figure 2.3. 
 
 
Fig. 2.3 Fictitious, homogeneous sub-compartment species inserted to mimic 
heterogeneity in species [A].  
 
The entities in [A] are not really transforming into those intermediate 
compartments [I1], [I2], [I3] before arriving in B. However, the ansatz in the 
mathematical modeling that the entities in [A] go through those fictitious intermediate 
compartments leads to sigmoidal time kinetics for [B]. This type of sigmoidal curve for 
[B] mimics the dynamics of the real system that has a significant amount of rate 
constant heterogeneity in species [A].  
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Fig. 2.4 Schematic of sigmoidal growth of the population of species [B]. 
 
To illustrate why these fictitious intermediate compartments produce a 
sigmoidal shape, I will use a simple case, with only one sub-compartment. Let us 
suppose that at t=0, 100% of the entities are in compartment A, as shown in Fig. 2.5. 
 
Fig. 2.5 Initial, t=0 populations for a system with one fictitious intermediate species.  
 
Entities in A need to go through the intermediate compartment I before the 
process of conversion from [I]à [B] commences. Because there is initially no 
population in [I], the process of conversion to [B] starts off slowly, with a lag time 
before the population of [B] starts to increase. 
Now, look at the situation at some intermediate time, after many 
transformations from [A] to [I] and transformations from [I] to [B] have occurred, in 
Figure 2.6. 
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Fig. 2.6 Populations for a system with one fictitious intermediate species (Fig. 2.4) after 
enough time has elapsed for significant transitions to occur. 
 
Now that there is significant population in [I], the process of transformation to 
[B] is much quicker.  
Next, look at the situation at long times, when most of the entities are in 
compartment [B]: 
 
Fig. 2.7 Populations for a system with one fictitious intermediate species (Fig. 2.4) at 
long times when most of the particles have completed the transitions to B.  
 
At long times, there are not many entities in [I] left to transform to [B].  The 
population of [B] slows in growth rate as the system approaches its asymptotic 
population distribution. The greater number of intermediate compartments between [A] 
and [B], the more sigmoidal and less exponential [B] will be.   
So far, I have described only the behavior of [B] from Fig. 2.2, and how Fig. 2.3 
can be used to get numerical results for [B(t)] when gk in Fig. 2.2 is not known. Since 
experimental measurements may be available for other species, e.g. [A], it is worth 
looking at their time development. In Figures 2.2, 2.3, and 2.5, the reactions occur only 
from left to right. This means that eventually, [A] will disappear and [I] will disappear, 
but with different time profiles. The species [A] experiences a simple first order 
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reaction that depends only on k1, and therefore [A] decays exponentially, Fig. 2.8. In 
Fig. 2.5 with a single intermediate species, fictitous or real, the initial population of [I] 
is zero. It then rises (Fig. 2.9) by gaining population from [A] with a rate constant k1, 
and then falls by converting to [B] with a rate constant k2. The relative values of k1 and 
k2 determine the details of the shape of the time dependence of [I], which is unlikely to 
be symmetric. 
 
Fig. 2.8 Exponential decay of [A] in Fig. 2.5. 
 
 
Fig. 2.9 Rise and fall of [I] in Fig. 2.5. 
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The model that I described above and showed schematically in Fig. 2.3 through 
Fig. 2.9 is overly simple. The direction of transitions is only from left to right. 
Therefore, at long enough times, the only species that remains is the last one. Real 
systems are usually more complicated. Reactions can go in both directions, and there is 
also the possibility for alternate paths that skip steps, such as going directly from A to 
B. Also, there may be back reactions that provide feedback, such as from [B]à[A]. All 
of these possibilities must be taken into account to produce a realistic mathematical 
model of the kinetics that is more complicated than the simple example given above. 
 
2.1.2 Compartmental Model Used In My Work  
The use of differential equations for studying the change in protein 
compartments with time is described in Chapter 4 of Protein Folding Kinetics by 
Nolting.44 Nolting shows coupled differential equations that are simple enough to have 
analytic solutions. The differential equations in Protein Folding Kinetics did not 
explictily take into consideration the heterogeneity in the rate constants.  
I used differential equations to study the changes in population in the following 
secondary structure configurations (species in the examples given above): random 
coil/β-turn, α-helix, β-strand/sheet. Each compartment was the percentage of amino 
acids from all the proteins in the system with a characteristic secondary structure. Many 
of the compartments also had structural characteristics in addition to the secondary 
structure.  
On the basis of experimental data, I developed a mathematical model to 
determine viable reaction pathways and rate parameters for peptide secondary structural 
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conversion and aggregation during the entire fibrillogenesis process from random coil 
to mature fibrils, including the species that accelerates the conversions. The numerical 
solutions yield graphs of concentrations of different molecular species versus time. The 
model and the rate constants include different molecular structural stages in the 
nucleation and polymerization process and provide insight on the molecular species 
involved in the fibril formation process. Determination of rate parameters for the 
various peptide structural conversion steps during fibril formation may be helpful in 
developing efficacious therapies for AD.  
 
2.1.3 Numerically Solving the Equations 
Finding an analytical solution to the complicated set of differential 
equations that I developed (see Chapter 3) would be extremely difficult, if not 
impossible. The number of equations that are coupled with each other is large, 
plus many of them are non-linear. Instead, I solved them numerically.  
There are different numerical algorithms for solving differential 
equations. An overview of some of these techniques is given in the book 
Computational physics by Newman.45 The numerical algorithms involve 
iterations over time steps.  
A simple algorithm is Euler’s Rule. The formula for Euler’s rule with 
one dependent variable is: 
𝑥 𝑡 + ℎ = 𝑥 𝑡 + ℎ ∙ 𝑓 𝑥, 𝑡    (2.6) 
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with 𝑑𝑥 𝑑𝑡 = 𝑓(𝑥, 𝑡) and ∆𝑡 = ℎ the size of the time step. The formula for 
f(x,t) is assumed known, so that its value can be determined at each step. 
Iteratively using this equation yields a solution with an error on the order of h2. 
The second order dependence is good because h is a small quantity. There is 
only one equation to use for Euler’s method and it’s a simple equation that 
comes from a Taylor expansion. However, by making things more complicated, 
we can reduce the algorithmic error to a higher power of h.  
 The second-order Runge Kutta method uses the slope at the midpoint 
between points at t and t+h, 𝑡 + !! ℎ. The second-order Runge Kutta method 
requires a knowledge of 𝑥(𝑡 + !! ℎ), which can be approximated using Euler’s 
method: 𝑥 𝑡 + !! ℎ = 𝑥 𝑡 + !! ℎ𝑓(𝑥, 𝑡). The equations used for second-order 
Runga Kutta (rk2) for a single dependent variable are: 
𝑘! = ℎ𝑓 𝑥, 𝑡    (2.7)  
𝑘! = ℎ𝑓 𝑥 + !!𝑘!, 𝑡 + !!ℎ   (2.8) 
𝑥 𝑡 + ℎ = 𝑥 𝑡 + 𝑘!   (2.9) 
The formula for f(x,t) is assumed known, so that its value can be determined at 
each step. You use the first equation to get k1. You then use the second equation 
to calculate k2. Based on knowledge of k2, you get the value of x(t+h). The error 
for rk2 is of the order of h3.  
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 Can we do better than rk2? How about fourth order Runga Kutta (rk4)? By 
adding linear combinations of Taylor expansions around various points, we can 
cancel terms in h3, h4 and so on. The equations for rk4 for a single dependent 
variable are: 
𝑘! = ℎ𝑓 𝑥, 𝑡    (2.10) 
𝑘! = ℎ𝑓(𝑥 + !!𝑘!, 𝑡 + !!ℎ)  (2.11) 
𝑘! = ℎ𝑓 𝑥 + !!𝑘!, 𝑡 + !!ℎ   (2.12) 
𝑘! = ℎ𝑓 𝑥 + 𝑘!, 𝑡 + ℎ   (2.13) 
𝑥 𝑡 + ℎ = 𝑥 𝑡 + !! 𝑘! + 2𝑘! + 2𝑘! + 𝑘!   (2.14) 
For each iteration, you start with the first equation and do the rest of the 
equations the order in which they are written above. There are two more 
equations in rk4 than in rk2, which requires additional computational time, but 
the benefit is that it has an algorithmic error on the order of h5, which means 
larger values of h≡Δt can be used. With larger values of h, the overall number 
of time steps can be reduced. Many people feel rk4 offers the best balance 
between number of calculations needed for each time-step and algorithm 
accuracy. It is by far the most commonly used method. For a system of coupled 
differential equations with more than one dependent variable, like my system, 
the equations are iteratively integrated for each dependent variable in parallel 
with the other dependent variables.   
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Although in general rk4 is the best method for solving differential 
equations, it depends on the particular situation. Remember that algorithmic 
errors are not the only errors. There are also round-off errors. Round-off errors 
come from the fact that a computer does not use an infinite number of digits 
after the decimal point. Round-off errors may seem trivial, but they can 
accumulate to produce large errors.46 Round-off errors are especially prevalent 
in the above-mentioned techniques because they involve getting slopes 
numerically, which involves subtracting two numbers that are close to each 
other. Subtracting two numbers that are close to each other can produce serious 
round-off errors.46 The idea is to have a good balance between algorithmic 
accuracy and the number of steps in the calculations. This is accomplished 
through the proper selection of the algorithm and the size of the time step. There 
is even the idea of varying the step size while doing the rk4 integration.46 
The differential equations representing the reaction pathway for my 
model were solved numerically using the computer software package 
Mathematica 7.0. Mathematica analyzes the differential equations and then 
determines which algorithm to use. Mathematica sometimes even switches after 
already starting to solve the equations if a better choice is found. 
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2.2 Molecular Dynamics of Amyloid Formation 
 
2.2.1 ccβ Peptide 
In order to perform detailed MD computational investigations, I focused my 
attention on a small, engineered peptide, ccβ (PDB ID code 1S9Z).38,39,40,41,42,43 ccβ, 
which has amino acid sequence SIRELEARIRELELRIG, responds to temperature 
changes by undergoing many of the structural transitions that occur in the amyloid 
formation processes of the larger, naturally occurring amyloid forming proteins and it 
has been demonstrated experimentally that coiled-coil trimers of ccβ can transform 
their structure and form amyloid-like protofibrils.42 Experimental observations42 find 
that at a temperature of 277K, ccβ exists as a stable coiled-coil α-helix trimer, whereas 
at 310K the helical structure converts to β-strands. MD investigations on a single trimer 
by Strodel et al.40 found that a β-sheet composed of three ccβ chains is stable up to a 
temperature of 440K.  
There are two important advantages to using ccβ in investigations of amyloid 
formation: its small size, and the fact that the control parameter for inducing structural 
transitions is temperature. Strodel et al.40 performed MD simulations of a trimer of ccβ. 
In order to speed up the process, they used replica exchange MD (REMD) simulations 
with the EEF1 force field. They found many pathways for the transforming of the 
coiled-coil ccβ trimer into a trimer β-sheet. They also found that only parts of the ccβ 
peptides first convert to β strands, which then further catalyzes the α to β secondary 
structure conversion.40  
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2.2.2 Molecular Dynamics Computer Simulations 
 Molecular dynamics is a computational technique that simulates the dynamics of 
a system of atoms as a function of time. On the most fundamental level, the evolution 
of the system is described by quantum mechanics. However, using quantum mechanics 
would be computationally very expensive. Instead, the dynamics of the atoms are 
handled classically. Although the energy functions that are used are classical, the 
parameters (such as the spring constants representing bonds) come from experiments or 
from results of ab initio quantum mechanics calculations involving electronic orbitals. 
The use of classical dynamics with quantum mechanically determined parameters 
makes it so that the calculations are quick enough to model many-atom systems such as 
proteins, but accurate enough to produce simulations that reasonably agree with 
experiment. Figure 2.10 is a schematic of the basics of the MD algorithm. 
 
Figure 2.10 Schematic of the MD algorithm. 
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There are different packages that perform MD, such as NAMD, Amber, and 
CHARMM. I used CHARMM (Chemistry at Harvard Molecular Mechanics) for my 
MD simulations. CHARMM is a versatile MD simulations package.  
 
2.2.3 Details of Molecular Dynamics  
The MD calculations compute the forces and energies based on the 
positions of all the atoms in the system. The interactions among atoms are 
classified into bonded and non-bonded.  
 
2.2.3.1 Bonded Interactions 
Bond Stretching  
A chemical bond is modeled as a spring with a classical form of the 
potential energy (coming from Hooke’s Law), but with the value of the bond 
spring constant kb derived from experiments or ab initio quantum mechanics 
calculations: 
𝑈 𝑟 = !!! (𝑟 − 𝑟!)!   (2.15) 
with r0 the equilibrium bond length. 
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Angle Bending 
 The angle bending energy is the energy needed to bend a bond from its 
equilibrium value, 𝜃!: 
𝑈 𝜃 = !!! (𝜃 − 𝜃!)!  (2.16) 
in which 𝑘!is the force constant whose value is derived from experiment or ab 
initio quantum calculations. The form of the energy is that of a simple harmonic 
oscillator, which is valid for small 𝜃. 
Torsions 
If four atoms i,j,k,and l form a bonded quartet (i bonded to j, j bonded to 
k, and k bonded to l), a dihedral angle can be defined. The dihedral angle for a 
sequence of atoms i-j-k-l is the angle between the normal to the plane defined 
by the atoms i-j-k and the normal to the plane defined by the atoms j-k-l.47 The 
terms dihedral angle and torsion angle are often used interchangeably.  The 
energy for the torsion angle 𝜑 is: 
𝑈 𝜑 = !!! [1+ cos 𝑛𝜑 − 𝛿 ]!!!!   (2.17) 
In the above equation, 𝑘!is a force constant (derived from ab initio 
quantum calculations or experiments). 𝛿 is the phase factor that puts the  
minimum potential energy at the correct torsion angles. 
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The idea is that n is the periodicity of the dihedral angle, or the number 
of cycles for a full 3600 rotation.48 For instance, N=2 means there is one 
potential energy function which has one minima and another energy function 
which has two minima, each 1800 apart. N is usually only one, although it can 
go up to six.49  
Improper torsions are used, when needed, to enforce the plane structure 
of a molecule. If instead of atoms i,j,k,l bonded in a sequence, you have a star-
like conformation with k bonded to atoms i,j,l you use an improper torsion 
angle. Atom k is called a branching point. Improper torsion energy can be used 
to obtain a particular geometry. The energy of an improper torsion angle is: 
𝑈 𝜔 = !!!!(!!!!)!  (2.18)            
with ω being the angle between the normal to the plane i,j,k and the normal to 
the plane j,k,l.                     
       
2.2.3.2 Non-Bonded Interactions 
Most of the non-bonded interactions are the electrostatic and van der 
Waals interactions. Non-bonded interactions are neglected between covalently-
bonded atom pairs and atom pairs that are separated by only two covalent 
bonds49 because the covalent bonds incorporate the non-bonded interactions.  
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Electrostatic Interactions 
 These interactions are the attractive and repulsive forces between charged 
atoms and molecules. The electrostatic energy function comes from Coulomb’s 
law: 
𝑈 𝑟 = !!!!!!"!!"!!!!!!!!!!    (2.19) 
In the equation above, NA is the number of point charges in molecule A and NB 
is the number of point charges in molecule B.   
There are also electrostatic interactions within a molecule: 
𝑈 𝑟 = !!!!!!"!!"  (2.20) 
 where the sum is over all pairs of atoms in the molecule besides nearest and 
next-nearest pairs. The permanent partial atomic charges that are assigned at the 
beginning of an MD simulation are determined by making an initial guess and 
then performing calculations in an attempt to get the results of quantum 
mechanics calculations or experiments. The assigned partial charges are 
modified based on the discrepancy between the result of the initial guess and 
results from experiments or quantum mechanics calculations. The process is 
repeated until there is good agreement between assigned charges and 
experiments or quantum mechanics calculations.  
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Lennard-Jones Interactions 
 The van der Waals interaction, which is the total energy of interaction 
between two non-bonded atoms, is approximated by the Lennard-Jones (LJ) 
potential50: 
𝑈 𝑟 = 𝐸![(!!! )!" − 2(!!! )!]   (2.21) 
E0 is the depth at the minimum in energy and r0 is the separation of the atoms at 
the minimum. The first term gives the repulsion that comes from the Pauli 
Exclusion Principle when the electron clouds overlap. The last term gives the 
attraction that comes from induced dipole moments. The LJ energy makes it so 
that two atoms’ nuclei stay a reasonable distance (but not too far) from each 
other. The reason eq. (2.21) is approximate is that it assumes atoms are 
spherical, since the energy function is independent of direction.  
 
2.2.3.3 Non-Bonded Interaction Cut-Off Distances 
 Calculating every non-bonded interaction would not be feasible 
computationally for protein systems, since the number of non-bonded 
interactions scales as the square of the number of atoms and proteins have 
thousands or more atoms. A common way to reduce the number of calculations 
for the non-bonded interactions is to use a cut-off distance.  
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 A cutoff distance is chosen by the MD user, beyond which no interaction 
is calculated. Care must be used when deciding where to have the non-bonded 
interactions cut-off, since electrostatic energies have infinite range. This cutoff 
creates a discontinuity if the energy abruptly drops to zero, which can lead to 
unreliable results or program termination. A switching function is used to avoid 
any discontinuities in energy.  
 Three parameters are associated with the cutoff distance: ctonnb, ctofnb, 
and ctnb. The switching function affects the non-bonded energies beginning at 
ctonnb, the smallest of the three parameters. The switching function takes the 
interaction smoothly to zero at ctofnb. The distance for generating the non-
bonded pair list is given by the value of ctnb.  The non-bonded pair list is 
updated periodically, and saves computational time by not having to check all of 
the atoms at every step to see if they are within ctofnb. The value of ctnb is 
slightly larger than ctofnb. For my system, cuton was 16Å, ctofnb was 18Å, and 
cutnb was 20Å. 
 
2.2.4 Numerical Time Integration for the Evolution of My System 
 Molecular dynamics makes use of Σ𝑭 = 𝑚𝒂 and 𝑭 = −𝛁𝑈 to calculate 
the acceleration of each atom based on the bonded and non-bonded forces of the 
surrounding atoms for each MD time-step. The acceleration is used to update 
the position and velocity of each atom for the next MD time-step. A time 
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interval of ~1fs is required to capture the highest frequency of motions of 
biomolecular systems, which is the vibrational motion of the chemical bond 
between a heavy atom and hydrogen. However, if the SHAKE command is used 
to constrain the bond length between a hydrogen and heavy atom a time-step of 
~2fs can be employed. SHAKE can be appllied to all the bonds and angles if 
selected. It uses an iterative scheme to exactly fix bond lengths.51 In the case of 
constraining the bond length between hydrogen and heavy atoms, SHAKE is an 
iterative procedure to adjust the hydrogen atoms after each step that the heavy 
atoms are integrated.48 
Some techniques that numerically update the position and velocity of 
each atom given the acceleration are described below. These techniques are 
referred to as finite-difference methods. These numerical integration techniques 
have much in common with the numerical techniques used in the mathematical 
modeling of the kinetics that is described above.  
Taylor Expansion 
 The simple Taylor expansion technique to advance the position and 
velocity with time of atom n uses these two equations48: 
𝑟!!! = 𝑟! + 𝑣!∆𝑡 + !! !!! (∆𝑡)!  (2.22) 
𝑣!!! = !!!!!!!!∆!   (2.23) 
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with ∆𝑡 as the time-step and Fn represents the sum of the forces on atom n. This 
formulation is quite simple, but results in large errors. 
Verlet Integrator 
 The Verlet Integrator is an improvement over the simple Taylor 
expansion. It is derived from using a backward Taylor Expansion and a forward 
Taylor expansion.48 The Verlet integrator uses this equation for advancing the 
position with time 
𝑟!!! = 2𝑟! − 𝑟!!! + !!! (∆𝑡)!   (2.24) 
The velocity at each point can be estimated by: 
𝑣! = !!!!!!!!!!∆!   (2.25) 
The Verlet integrator gives high-precision values of position (errors on 
the order of ∆𝑡!) and is independent of velocity propagation.48 However, the 
velocity propagation from the Verlet integrator can have large errors on the 
order48 of ∆𝑡!  and the velocity can only be computed after the position is 
computed. It also requires a value of the position for the n-1 time step. 
Sometimes, a simple Taylor expansion is used to get the position at a fictitious -
1 time step to get the algorithm started from the initial structure. (The starting 
structure is at time step zero.)   
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Leap-Frog Integrator 
 The Leap-Frog integrator (also called Verlet Leap-Frog integrator) is a 
modification to the basic Verlet integrator.48 The Leap-Frog integrator uses 
these two equations for advancing the system with time: 
𝑟!!! = 𝑟! + 𝑣!!! !∆𝑡   (2.26)          
𝑣!!! ! = 𝑣!!!/! + !!! ∆𝑡  (2.27) 
As can be seen from equations (2.26) and (2.27), the Leap-Frog Integrator is so 
called because during a time step ∆𝑡 the velocty leaps ½ time step ahead of the 
position as it is calculated. When the position is calculated, it leaps ½ time step 
ahead of the velocity. The current velocity can be calculated using: 
𝑣! = (𝑣!!! !+𝑣!!! !)/2  (2.28) 
or other methods that introduce smaller errors than equation (2.28). The position 
in the Leap-Frog algorithm has an error for position of  ∆𝑡!, the same as Verlet. 
However, the error in the velocity calculated using Leap-Frog at half time steps 
is ∆𝑡!, which improves over the Verlet algorithm of ∆𝑡!.  
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Simply decreasing ∆𝑡 to try to increase the precision would require more 
time steps to be calculated. This not only increases the computer time needed, 
but also increases the total round-off error.46 A rule of thumb for selecting ∆t is: 
∆𝑡 = 𝜏 20                                (2.29) 
in which 𝜏 is the period of the fastest motion.48  
 
2.2.5 Replica Exchange Molecular Dynamics 
A complex system like a protein with many moveable and interacting parts is 
likely to have a complicated energy landscape with many hills and valleys. Exploring 
such a landscape to find preferred, low enegy configurations with MD simulations can 
be difficult. The initial configuration is often chosen for reasons of convenience, but 
because of high barriers, the system may be unable to leave the initial location in 
configuration space if the temperature of the simulation is low. Conversely, if the 
temperature of the simulation is set very high, the system can quickly change its 
configuration from the initial one, but may never settle into any configuration because 
high temperatures cannot distinguish potential energy minima. REMD52,53,54 is used to 
allow the system to move around configuration space but also settle into a region that 
has a potential energy minimum. Because of this, REMD is known as a technique of 
enhanced sampling. 
Replica Exchange Molecular Dynamics is performed by first creating many 
replicas of the initial configuration of the system and assigning each replica a different 
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temperature. Each replica is independently but simultaneously simulated by MD. After 
a fixed number of MD time steps, a Metropolis-type test is applied to the replicas to 
decide whether to swap replicas at adjacent temperatures. The temperature exchange 
probability is given by Pij=min{1,exp(-∆) } with ∆=(Ej-Ei )*[1⁄(kTi)-1⁄(kTj)] and Ej the 
potential energy of replica j. After this test for swapping is performed and the replicas 
that fit the criteria are temperature swapped, another fixed number of MD steps is 
performed on all replicas, followed by another test for swapping adjacent temperatures, 
and so on. During stages when a replica is at high temperatures, it is able to escape 
from configurational kinetic traps (energy minima) and sample large regions of 
structural configuration space, but is unlikely to settle into any specific, low energy 
configurations. However, a replica that finds a low energy configuration is likely to 
swap to a lower temperature and thus increase its probability to remain in a low energy 
configuration.   
 
2.2.6 Implicit Solvation 
 The natural environment for a protein system is water. Explicitly including 
water atoms in addition to protein atoms is computationally expensive. Ninety 
percent or more of the computation time may be spent on water-water 
interactions, which are not directly relevant to the protein dynamics. In a protein 
system, often the water-water dynamics are not of major importance. To speed 
up the calculations, implicit solvents can been used in MD simulations. Chapter 
7 in Computational Biochemistry and Biophysics48 gives general descriptions of 
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different ways to represent the water solvent implicitly, rather than using 
explicit water molecules. 
 One such implicit solvation model is EEF1.55,40,56 It uses an excluded volume 
implicit solvation model and the CHARMM 19 polar hydrogen energy.49  It also 
implicitly models the dielectric screeing of water molecules by a distance-dependent 
dielectric function, ε =r,57 as well as neutralizing ionic sidechains.57,49 It also uses the 
solvent exclusion effect, which assumes that the solvation free energy of each group is 
equal to a reference solvation free energy of that group minus the solvation it loses due 
to solvent exclusion by other atoms around it.57 
Strodel et al. performed REMD and basin hopping global optimization 
to study the KFFE monomer and dimer energy landscapes, using four implicit 
solvent models.40 They found that of the four models they tested (EEF1 and 
three generalized Born models) EEF1 provided the best description for KFFE 
when comparing to experimental results. 
In order to model solvent friction and Brownian motion of the solvent, 
the Langevin dynamics method is often used with an implicit solvation model. 
The Langevin equation is: 
𝑚! !!!!!"! = −∇!𝑈 𝑟 −𝑚!𝛽𝑣! 𝑡 + 𝑅!(𝑟)  (2.30) 
𝛽 is the reduced friction coefficient. Ri(t) is the random force representing 
stochastic collisions between solvent molecules and solute.   
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2.2.7 Confining Potentials and Periodic Boundary Conditions 
 Periodic Boundary Conditions (PBC) can be used in MD simulations to decrease 
the volume of the system that is included in the simulations and thus allowing the 
simulations to run faster.49 A boundary is created in the shape of a cube. When an atom 
exits on the left side of the boundary, it enters on the right side of the boundary. The 
same thing occurs for the top and bottom edges of the PBC cube, as well as the front 
and back edges of the cube. 
 Another way to confine the system is by using a repulsive spherical 
potential to push the atoms back once they have encountered the confining 
potential.  
 
2.3 My Particular Molecular Dynamics Simulation 
  To speed up the structural conversion process so that I could investigate 
the β formation and aggregation dynamics, I performed an REMD simulation 
using the CHARMM EEF1.1 force field with the MMTSB toolset,58 using 
CHARMM version 35b2. EEF1.1 is the same as EEF1 mentioned above, except 
that EEF1.1 contains some adjustments in the parameters describing partial 
charges. The adjustments are empirical adjustments and are made because some 
of the parameters in the EEF1 force field model simulate the ionizable side 
chains too strongly.    
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I used an MD step of 2fs and I had CHARMM write every 500 steps 
(making each frame 1ps apart). My REMD simulation checked every 500 MD 
steps (every 1ps) for whether to swap temperatures between replicas of adjacent 
temperatures. I used exponential spacing of the temperatures with a range of 
380K-600K.  
In order to make up for the Brownian motion and frictional effects of the 
solvent that are not simulated in the EEF1 implicit solvent, I used Langevin 
Dynamics with a reduced friction coefficient of 1. 
The proteins were confined by a spherical quartic potential that had the 
value zero for r<DROFF and a value of Force*Δ2*(Δ2-P1) for r>DROFF with 
Δ=r-DROFF. I used Force=0.2 and P1=2.25. A DROFF of 600Å was used to 
minimize the effect of the confining potential on the aggregation process.    
 The number of interchain and intrachain hydrogen bonds were calculated using 
Visual Molecular Dynamics. Many of the parameters were calculated using Python 
programs analyzing large PDB files containing the coordinates of each atom during 
each frame.    
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3. MOLECULAR RATE CONSTANTS FOR AMYLOID β FIBRILLOGENESIS 
An extensively studied, naturally occurring peptide system is the amyloid beta 
precursor Aβ peptide, which is responsible for amyloid deposits in AD.59 On the basis 
of experimental data, I have developed a mathematical model for the reaction pathways 
and determined rate parameters for peptide secondary structural conversion and 
aggregation during the entire fibrillogenesis process from random coil to mature fibrils, 
including the molecular species that accelerate the conversions. The model and the rate 
parameters include different molecular structural stages in the nucleation and 
polymerization processes and the numerical solutions yield graphs of concentrations of 
different molecular species versus time that are in close agreement with experimental 
results. My model also allows for the calculation of the time-dependent increase in 
aggregate size.  
In Section 3.1, I give a general description of Aβ Proteins. Section 3.2 describes 
the various structures in my model. In Section 3.3, I describe model details and the 
results of fitting my model to experimental data.  
 
3.1 Description of Aβ Proteins 
A protein that is produced normally in the human body throughout life is Aβ. It is 
not known what function the Aβ protein in humans has, if any. It is cleaved from a 
larger precursor protein, AβPP. Aβ amyloids in the neuropil are associated with AD.  
The primary structure of Aβ is: 
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA. 
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Naturally occurring Aβ peptides have a length in the range of 39–43 amino acids. 
Experiments have elucidated valuable structural information of variants such as Aβ(10-
35), Aβ(1-40) and Aβ(1-42) peptides.60,61,62 The predominant forms of Aβ produced in 
vivo are Aβ(1-40) and Aβ(1-42).  
 Different segments of Αβ have different properties. For instance, Aβ(1-40) has 
48% hydrophobic residues and 40% hydrophilic residues whereas Aβ(16-22) has 71% 
hydrophobic residues and 29% hydrophilic residues. Different segments within Aβ(1-
40) have different secondary structure propensities.63  
 
3.2 Description of Various Structures in My Model 
After dissolution, Αβ proteins tend to exist as monomers, dimers, and very 
small oligomers of mostly unstructured random coil and β-turn peptides, along with a 
small amount of structured β-strands and β-sheets. They then form micelles, which are 
loosely bound disordered aggregates. These micelles then break apart into nuclei. The 
nuclei are small and reactive to proteins and brain cells. They are β-aggregates and 
grow by forming with other nuclei and having monomers attach to them. When they 
have these monomers attach to them, they tend to catalyze the added proteins to the β-
strand state. These nuclei continue to grow until they are large enough to be called 
protofilaments. 
Protofilaments are composed of β-sheets parallel to each other. Protofilaments 
wrap around each other like strands of rope to make protofibrils. Protofibrils are soluble 
and can grow either by attaching of single monomers or attaching of all kinds of β-
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aggregates. When protofibrils are large enough they become fibrils, also called mature 
fibrils.  
The description above is a simple one. However, in real Αβ proteins, there are 
many different oligomers and pathways toward fibrils.9 Assuming a simple process 
toward aggregation allowed me to be able to define a functional model for Αβ 
fibrillation. 
 
3.3 Results 
The role of fibrillar Αβ in AD has stimulated interest in the kinetics of Αβ fibril 
formation. Determination of rate parameters for the various peptide structural 
conversion steps during fibril formation may be helpful in developing efficacious 
therapies for AD. Various research groups have been successful in performing very 
difficult experiments.  
Kinetic models that include reaction pathways and rate parameters for the 
various stages of the process can be helpful toward understanding the dynamics on a 
molecular level. Rates for peptide structural transformations that nucleate β-structure, 
as well as rates for aggregation/polymerization into mature fibrils are especially 
interesting. There are experimental data on rate parameters for some of the stages of the 
fibril formation process. These include the investigations on the elongation and 
nucleation rate parameters for fibrillogenesis at low pH,2 rates of nuclei production and 
association,64 and lag time and rate of aggregation.65 Kinetic rate equations were used 
by Pallitto and Murphy7 to model folding and aggregation. Kinetic models can further 
benefit from experiments that have shed light on aspects of the process of Αβ 
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aggregation from random coil to mature fibril. Kirkitadze et al.28 were able to measure 
the temporal changes of concentrations of different types of secondary structures: 
random coil, α-helix, β-strand/sheet, and β-turn for both Αβ(1-40) and Αβ(1-42). These 
measurements were done over a period of 20 days for Αβ(1-40) and 10 days for Αβ(1-
42), allowing enough time for fibrillogenesis to occur. Fezoui and Teplow36 measured 
the concentration of prefibrillar and fibrillar β-structure as a function of time in 
different solvent conditions. 
Determination of rate parameters for the various peptide structural conversion 
steps during fibril formation may be helpful in developing efficacious therapies for AD. 
The numerical solutions of my model yield graphs of concentrations of different 
molecular species versus time. With the proper choice of transition rate parameters, my 
model is able to nicely fit the time dependence of the concentrations measured 
experimentally by Kirkitadze et al.,28 Walsh et al.,37 and Fezoui and Teplow.36 My 
model and the rate constants include different molecular structural stages in the 
nucleation and polymerization process and provide insight on the molecular species 
involved in the fibril formation process.  
 
3.3.1 Model of Reaction Pathways and Experimental Data 
On the basis of the experimental and computational results, Bitan et al.66 
hypothesized that hydrophobic residues on different helical peptides might aggregate to 
create a paranucleus, which can then transform to amyloid protofibrils. In addition, it 
has been suggested that the process of structural conversion may be accelerated by the 
presence of prefibrillar β-aggregates of varying sizes.33,67 Experimental data28,2,37 
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suggest that the population of the α-helix species increases rapidly (and non-linearly) as 
the β-structure begins to appear near the end of a lag phase. The lag phase (also called 
lag time) is the time it takes for a significant number of nuclei to form. During the lag 
phase, not much structural conversion takes place, which shows that the appearance of 
β-species plays a role in the structural conversion. Although a detailed molecular 
description of the nucleation mechanism is still not fully understood, Auer et al.68 
suggest that the surface of a growing β-sheet acts as a substrate for the attachment of α-
helical peptides during the aggregation process. Therefore, I assumed that the random 
coil→α-helix transition is affected by the presence of β-strands. Some experiments69,70 
suggest that fibrillogenesis proceeds from random coils directly to β-structure. The 
prefibrillar structures can serve as toxic elements that facilitate the structural conversion 
from random coil to α-helix, and also in the conversion from α-helix to β-structure. 
Using differential equations for studying the change in protein compartments 
with time is described in Chapter 4 of Protein Folding Kinetics by Nolting.44 Nolting 
shows coupled differential equations that are simple enough to have analytic solutions. 
The differential equations in Protein Folding Kinetics do not take into consideration the 
heterogeneity in the rate constants. The set of differential equations for my model is 
more complicated.  
On the basis of experimental observations described in an article by 
Kirkitadze et al.,28 I made the following assumptions in formulating my reaction 
pathway model: (i)The conformational transitions which occur during 
fibrillogenesis proceed as random coil à α-helix à β-strand/sheet à β-
aggregate/protofibril à mature fibril, (ii)the processes of random coil à α-
 45 
helix, and α-helix à β-strand conversion are accelerated by the presence of 
toxic β-strand aggregates, (iii) random coil/β-turn structures incorporated in the 
mature fibril state retain their unstructured properties.  
With these basic assumptions, I developed a kinetic, state-transition 
model (Figure 3.1) in which the amino acid configurations are grouped into 
various stages during the fibril formation process. I used differential equations 
to study the changes in population in these secondary structure configurations: 
random coil/β-turn, α-helix, β-strand/sheet. Each compartment represents the 
percentage of amino acids from all the proteins in the system with a 
characteristic secondary structure. Many of the compartments also had another 
characterstic in addition to the secondary structure, as described below. 
 
 
Figure 3.1 A state transition model of the structural conversion process of the 
Aβ formation process. To simulate the heterogeneity in βN structure, the βN 
phase is treated purely mathematically as a series of n fictitious sub-
compartments. For all sub-compartments, the rate of transition to the next sub-
compartment is given the same value, nk3. The reason for this is given in detail 
below.  
 
The notation for the species and kinetic parameters included in the 
schematic diagram of Figure 3.1 are explained in Table 3.1. 
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RCT0  Initial combined concentration of random coil/β-turn 
 RCT1  Fraction of inital concentration of random coil/β-turn that 
   retain the random coil structure and are either directly       
   incorporated into mature fibrils or remain isolated as   
   monomers/dimers  
α  α-helix concentration 
 βN  Concentration of non-toxic β-strands/sheets/aggregates   
   such as micelles 
βTx  Concentration of β-strand aggregates such as protofibrils 
 βM  Concentration of larger, non-toxic β-aggregates such as mature  
   fibrils 
 k0, k1, k2, k3,  Rate parameters for transitions from one structural state to another 
k4 
ε  Fraction of initial monomers/dimers that are stable and do not  
  participate in fibrillogenesis 
 
Table 3.1 Parameters Used in This Model. 
 
The differential equations used to quantify my model presented in Fig 3.1 are 
equations (3.1)-(3.8).  
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Summing the right side of all the equations (3.1)-(3.8) gives zero because my 
model had no proteins entering or leaving, and the differential equations are consistent 
with the mass action principle. 
Figure 3.1 and equations (3.1)-(3.8) represent a model with the 
following details. An initial combined concentration of random coil/β-turn 
configurations is represented by RCT0. A fraction of the RCT0 molecules remain 
in the random coil configuration and are denoted as RCT1. The RCT1 molecules 
are composed of two types. One component of RCT1 contains molecules that 
undergo rapid and irreversible commitment to stable monomers/dimers, as 
found experimentally in Pallitto and Murphy,7 and represented by the path with 
rate constant koε.  
The other contribution to the population of RCT1 is from RCT0 amino 
acids that are either part of a mature fibril or sequestered in a mature fibril. The 
process of RCT0 amino acids becoming either part of a mature fibril or 
sequestered in a mature fibril requires mature fibrils and its rate depends upon 
[βM]. The experimental results in Fig. 1b of Kirkitadze et al.28 show that the 
combined random coil/β-turn content levels off at long time scales, which 
implies that as the process of structure conversion proceeds and prefibrillar and 
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fibrillar structures start to form, some initial random coil/β-turn components 
retain their structures and may never convert to α-helix. Another study37 found 
significant amounts of random coil/β-turn incorporated into both protofibril and 
fibril structures. Since mature fibrils are stable, the random coil/β-turn 
components in these structures can no longer transform to other structures.63,71,72 
The fraction of RCT0 that does not convert to RCT1 follows the main 
pathway for fibrillogenesis in Fig. 3.1 and transforms into α-helix secondary 
structure configuration with a rate k1, and this process is accelerated by the toxic 
β-aggregate species that are grouped in βTX. The βTX compartment includes toxic 
species of varying sizes, including small aggregates.  
There are two important issues that must be explained by the model: 
determining a molecular mechanism that generates the lag phase observed in the 
experiments, and determining a reaction pathway mechanism to correctly 
reproduce a rapid drop-off at long times in the concentration of α-helix. I first 
address the issue of a molecular explanation of the lag phase.  
 
3.3.2 Modeling of the Lag Phase 
For the specific experiments that are analyzed in my work, there is little 
change in the concentration of any of the different species during the first four 
days of observation. Circular dichroism measurements revealed that the Aβ(1-
40) oligomerization was preceded by an increase in α-helical content from 3% 
to >30%. The α-helix content begins to rise after four days of incubation 
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whereas the fibrils are observed only after six days. Similar results from MD 
simulations were obtained by Bumketner et al.,73 in which a modest α-helical 
content was observed.  
The sub-compartmentalization of the βN phase is introduced to explain 
this lag phase. The series of βN compartments is used as a mathematical method 
to represent a single phase that has heterogeneous structures with a wide range 
of rate constants. If a single βN compartment is used, representing a relatively 
homogeneous population, there is no initial delay in change in concentrations. 
Mathematically, if we ignored the heterogeneity in βN by using only a single βN 
compartment with a single rate constant k3, no lag phase occurs because β-
strand/sheet structures that are included in the initial preparation as βN are 
allowed to convert to toxic protofibrils (βTX) with a single rate constant k3 and 
the resulting βTX accelerates the RCT0→α-helix conversion process. A single 
non-toxic βN compartment is equivalent to the assumption of a homogeneous 
collection of βN structures, all with the same value of k3. However, βN 
aggregates may contain a range of sizes or geometries. This structural 
heterogeneity74 complicates the conversion process and produces a distribution 
in the transition rate from βN→βTX. This structural heterogeneity is the 
molecular basis for explaining the lag phase and is incorporated into my model. 
The effects on the kinetics of a single process due to a heterogeneous 
distribution in reaction rate constants can be mathematically simulated in a 
model by incorporating a series of ‘n’ fictitious steps (Fig. 3.1). The method of 
multiple stages, wherein a single compartment is broken into several identical 
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compartments in series, is widely used in epidemiological models.75,76,77 Each 
sub-compartment ‘i’ acts as a homogeneous collection of molecules. In order 
for the average time for the process to remain as τ=1/k, all sub-compartments 
have the same mean waiting time, τ′i=τ/n=1/nk and the same rate parameter 
k′=nk. The resulting average total time spent in all n sub-compartments is just 
τ=nτ’i=n(1/nk)=1/k, the same average total time as if it was a single 
compartment with rate constant k. Though the average time to transition from 
βN→βTX is the same whether there is a single compartment with a single rate 
parameter k3, or a series of n fictitious compartments (as in the model), each 
with rate parameter nk3, the probability distribution of individual molecular 
reaction times is not the same.  
The probability that a random variable is between two values is the 
definite integral of the probability function between these two values. For the 
simple process of entities transforming from compartment A to compartment B 
with a single rate parameter, the probability density function for molecular 
reaction times is exponential, as shown in Fig 2.8.  
For a series of compartments in my model, the probability density 
distribution is described by a gamma function. The sub-compartmentalization 
method generates the same distribution in reaction times as expected from a 
heterogeneous collection of structures, each performing a single step conversion 
at a different rate. The probability density function for βN→βTX reaction times 
p(t) is given by p(t)=tn−1e−nkt [(nk)n/Γ(n)], where Γ(n) is the gamma function, and 
n is the number of sub-compartments. The variance in reaction rates of this 
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distribution is given by 1/(nk2). The variance of this distribution is manifested 
on a macroscopic experimental level by producing a lag phase in the 
aggregation process. The number of sub-compartments in the model can be 
estimated by fitting the experimentally observed lag phase.  
The gamma distribution of reaction times for the βN structures is more in 
alignment with what is known about the molecular species. The βN species 
undergoes aggregation as it transforms into the toxic βTX species. The dynamics 
of aggregation are complex with many different molecular routes, and therefore 
it is expected that aggregation of β-strands/β-sheets into protofibrils is not a 
homogeneous process. In light of this, we can view the mean reaction time as a 
mean aggregation time. Interestingly, the lack of lag phase with the use of a 
single compartment, homogeneous βN resembles the faster nucleation and 
polymerization processes observed for Aβ(1-42)78,28 which displays a 
significantly shorter lag time as compared to Aβ(1-40). I focus on Aβ(1-40) 
because there are more experimental data points than for Aβ(1-42). 
 
3.3.3 Modeling the Rapid Drop-Off at Long Times in α-Helix 
Concentration 
Another important aspect incorporated into my model is the ability of 
βTX to accelerate the process of α-helix→β-strand conversion in order to have 
the theoretical α-helix curve drop off at long times as quickly as the 
experimental data in the tail after the peak. In order to match the quick drop 
observed experimentally, the degree of this dependence had to be enhanced by 
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introducing the exponent q in the βTX activity so that the rate of conversion from 
α-structure is given by k2[βTX]q. Because of the complex nature of the 
aggregation process, a higher-order concentration dependence (q>1) is not 
unusual. 
 
3.4 Numerical Results Using My Model to Fit the Experimental Data 
I developed my kinetic model to explain the experimental data on the Aβ 
fibrillogenesis process from several studies. In one study, Kirkitadze et al.28 
experimentally followed the time course of the fibril formation process and measured 
the percentages of various structural elements for both Αβ(1-40) and Αβ(1-42) peptides. 
I fit my theoretical curves to the experimental data for Aβ(1-40) fibrillogenesis 
presented in Fig. 1b of Kirkitadze et al.28 The Kirkitadze data are reproduced as the 
points in Fig. 3.2. 
In order to monitor the development of various secondary structural 
motifs during fibrillogenesis, they initialized their Aβ peptide samples by 
subjecting them to a dissolution process. This dissolution process produced a 
starting solution of mostly unstructured random coil and β-turn peptides, along 
with a small amount of structured β-strands and β-sheets. Over a period of three 
weeks, the solution was subjected to circular dichroism (CD) analysis to track 
the time evolution of random coil, β-turn, α-helix, and β-strand concentrations. 
Accurate estimation of the β-turn content was relatively more difficult than 
accurate estimation of α-helix and β-strand concentrations as a result of the β-
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turn’s structural variations. Two different deconvolution algorithms for spectral 
analyses (CDANAL79 and CONTIN/LL80) yielded the same results for the 
concentrations of both α-helix and β-strand but yielded quite different β-turn 
content. However, the sum of the random coil and the β-turn concentrations 
remained the same using either method. Since both methods give the same 
results for the combined concentrations of random coil and β-turn, my model 
treats them together. 
The rate parameters for the aggregation kinetics depend on factors such 
as pH, initial concentrations, temperature,81 and methods of preparation for the 
initial protein sample.28,3,81 Therefore, lag times vary greatly among 
experiments.13,81,82 Lag time is highly dependent on initial concentrations 
among the different species as it is sensitive to various assembly states of the β-
aggregates.83 
 
Figure 3.2 Experimental data (points) from Kirkitadze et al.28 fit with theoretical curves 
derived from the model of Fig. 3.1. 
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Following the experimental conditions, I set the initial contents to be 
RCT0(t=0)=88.1%, βN1(t=0)=11.9%, and zero for all other compartments. The 
concentration of the monomers/dimers is difficult to measure, and quantitative 
information is not available.7 Therefore I set ε=0 in my work. The parameter ε can be 
appropriately adjusted when experimental data are available. The model includes the 
reaction pathway with sub-compartments that generate a time lag that results from 
nucleation and the resulting curves accurately fit the data.  
In Figure 3.2, I display my fit to the experimental data presented in Kirkitadze 
et al.28 The following values of the rate parameters generated the curves: k0=0.590/day, 
k1=0.672/day, k2=0.678/day, k3=0.0392/day, and k4=0.554/day. The number of sub-
compartments is n=4, and the exponent is q=2. From Fig. 3.2, it is clear that my model 
accurately fits the experimental data. It successfully reproduces the lag phase kinetics 
involved in the fibril formation process. My model also reproduces the sharp drop in 
the experimental α-helix curve near the end of the process. 
I further use my model to fit other experimental data. Specifically, I fit the 
experimental data by Walsh et al.37 and by Fezoui and Teplow.36 Walsh et al.37 
performed experiments with the low molecular weight Aβ(1–40) peptide and followed 
the conformational changes during the fibril formation process with CD spectra for 
over 30 days. The data points in Fig. 3.3a show the secondary structure content plotted 
against time as given in Table I of Walsh et al.37 Their data are also consistent with 
similar observations that fibrillogenesis involves formation of intermediate α-helix 
secondary structure during the conformational transition from random coil to β-
aggregates. The curves in Fig. 3.3a show the fit with my model. Following the 
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experiments, I set the initial contents to be RCT0(t=0)=76%, α(t=0)=11%, 
βN1(t=0)=13%, and zero for all other species and compartments. The transition rates and 
other parameters that generated my fitting curves were k0=0.0154/day, k1=0.0318/day, 
k2=0.0282/day, k3=0.0565/day, k4=0.520/day, and the number of sub-compartments 
n=6. I note that different experimental conditions will affect the rates of different steps 
in the process. For example, though the temporal trends are similar, the data from 
Walsh et al.37 display much smaller changes in concentrations than the data from 
Kirkitadze et al.28 because of differences in experimental conditions. Therefore, the 
values for the rate parameters used in the fit in Figure 3.3a are different than those used 
for the curves in Figure 3.2. The exponent q=2 remains the same as used for the curves 
in Fig. 3.2.  
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Figure 3.3 (a) The experimental data points from Walsh et al.37 showing the secondary 
structure content obtained by deconvolution of CD spectra. The curves are the numerical 
results from fits obtained using my model. (b–d) Data points from Fezoui and Teplow36 
showing the temporal changes in the β-structure content for Aβ(1-40) fibrillogenesis at 
different TFE concentrations. 
 
3.4.1 Co-Solvents 
 Experimentalists often use co-solvents with water, which changes the fibril 
formation dynamics as compared to a sytem of proteins in pure water. Urea is 
commonly used to denature proteins.84 Alcohols are often used as co-solvents.84 A good 
review of alcohol co-solvents is given by Buck.85 
Trifluoroethanol (TFE) is a fluorinated alcohol. Proteins in TFE/water solution 
having different secondary structure dynamics than when in a pure water solvent.86 The 
effects of TFE seem to depend on amino acid sequence.85 It is well established that TFE 
promotes formation and stabilzation of α-helices and hairpins.87 A theory as to why 
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TFE favors the formation of intrachain hydrogen bonds is that TFE molecules coat the 
outside of a protein.86 The coating displaces water molecules86 which removes 
hydrogen bonding partners to which backbone atoms could hydrogen bond.86 The 
displacement of water also creates a lower dielectric environment which promotes 
electrostatic interactions.86 Water has one of the largest dielectric constants among 
fluids, 78 at 250C.88 Trifluoroethanol does not does not disrupt severely the 
hydrophobic interactions within a protein86 or may even strengthen them, which is in 
contrast with most other organic solvents.  
However, it is not well established whether TFE promotes or inhibits formation 
of β-sheets. Trifluoroethanol has been known to disrupt and also enhance quaternary 
interactions. The hydrophobic interactions between proteins tend to be weakened by 
TFE. The TFE molecule is approximately nine times larger than the water molecule.  
Circular Dichroism spectropolarimetry was done on T4 LYS (11-36), a peptide 
dervied from a region of the T4 lysozyme molecule, by Anderson et al.89 It was found 
that as the TFE content rose to 20%, the β-sheet content grew from 26 to 38%.89 
However, as the TFE content then rose to 50%, the β-sheet content decreased to 15%.89 
In terms of the energy landscape picture of Fig. 3.4, TFE lowers the energy of 
the α-helix state. In addition, the height of the barriers for the RC→α-helix transition 
and the α-helix→β-structure transition can be affected by TFE, as evidenced by the 
temporal data in Fig. 2a of Fezoui and Teplow.36 
Fezoui and Teplow36 show that the amount of Aβ, the protein whose fibrils 
cause AD, goes down with increasing TFE concentration and is 0 for 30% and higher 
TFE concentration.36 It also shows increasing amounts of α-helix with increasing TFE 
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concentrations.36 However, the fibrils actually form faster when the TFE concentration 
is raised up to about 20%. Experiments have found that the random coil to fibril 
formation process involves significant α-helix intermediates for Aβ and that the 
formation of these α-helix intermediates is “on pathway” for fibril formation.90,28 
Insight into the role of the α-helix intermediate in the fibrillization process is provided 
by experiments36 that use TFE which facilitates and stabilizes helical structure. At TFE 
concentrations below 20%, the fibril formation process is accelerated by increasing the 
concentration of TFE. However, the addition of higher concentrations of TFE can 
potentially slow fibril formation, implying that the α-helix intermediate91 becomes too 
stable and does not allow the progression to the β-structures necessary for fibril 
formation. The dependence of fibril formation on the concentration of TFE can be 
explained thermodynamically with the help of an energy landscape diagram. A 
schematic energy landscape representing these structural stages is shown in Fig. 3.4. 
Increasing the TFE concentration deepens the energy minimum corresponding to the α-
helix structure, which can facilitate the transition from random coil→α-helix, a 
necessary step in fibrillogenesis. At low TFE concentrations, fibrillogenesis continues 
with the transition from α-helix→β-strand. However, at high TFE concentrations, the α-
helix structure becomes stabilized so strongly that the α-helix energy minimum is 
difficult to escape. The α-helix→β-strand conversion is impeded and fibril formation is 
hindered. 
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Fig. 3.4 Schematic energy landscape of Aβ secondary structure conversion as a 
function of arbitrary structural reaction coordinates x and y. TFE stabilization of α-helix 
structure is represented by increasing the depth of the α-helix energy minimum. If the 
α-helix minimum is too deep, the peptide may find it difficult to undergo the 
conversion of α-helix→β-strand. The dotted arrow represents a possible pathway in 
which the random coil converts directly to β-structure, bypassing α-helical structure. 
 
 
Figure 3.3b-d shows the experimental data points from Fezoui and Teplow,36 
which investigated the effects of α-helix stabilization on Aβ fibrillogenesis. In that 
work, Fezoui and Teplow used several different concentrations of helix stabilizing TFE 
solution and followed the rates of fibril formation and fibril elongation. They concluded 
that the helical intermediate structures play a crucial role in peptide oligomerization, 
which is followed by the conformational reorganization into extended β-sheets. Without 
TFE (0% concentration), the time course of β-structure content as shown in Figure 3.3b 
is similar to that displayed in Figure 3.2. 
Since Figure 3.3b-d only contains data for one molecular structural component, 
it may be possible to fit the data using different parameter sets because the fits are not 
constrained as strongly as for the data in Figure 3.2 and Figure 3.3a. Since the 
experimental conditions were significantly different in Figure 3.3b-d, I expect that the 
fit parameters may also be different. For example, the data in Figure 3.3b-d result from 
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different initial concentrations of α-helix. Differences in initial conditions, temperature, 
and TFE concentration lead to important differences in the time required before the β-
structure content starts to dramatically increase and this will have a strong effect on the 
values of some of my model's parameters.  
When the TFE concentration is increased up to 20%, the fibril formation 
process is accelerated and the lag phase is decreased. For the condition of 0% TFE in 
Figure 3.3b, the fit parameter values are k0=3.00/day, k1=0.448/day, k2=0.310/day, 
k3=0.0512/day, k4=0.107/day, q=2, and n=4. The fit parameters for 10% TFE in Fig. 
3.3c are k0=1.23/day, k1=0.463/day, k2=0.350/day, k3=0.100/day, k4=0.733/day, q=2, 
and n=3. For 20% TFE in Fig. 3.3d, they are k0=0.771/day, k1=0.0116/day, 
k2=0.467/day, k3=0.774/day, k4=1.00/day, q=2, and n=1. For Fig. 3.3b-d the initial 
content of RCT0 and α-helix were set to the values given in Table 1 of Fezoui and 
Teplow.36 The initial β content that I used was determined from the data plots in Figure 
2a of Fezoui and Teplow36 and divided as follows for the calculations in this paper: 
Figure 3.3b (0% TFE): βN1(t=0)=18.1%, βN2(t=0)=5.0%; Fig. 3.3c(10% TFE): 
βN1(t=0)=15%, βN2(t=0)=2.0%; Fig. 3.3d (20% TFE): βN1(t=0)=7.0%, βTX(t=0)=1.0%. 
All other species and compartments were assigned initial contents of 0%.  
My model fits the lag phase for various TFE concentrations up to 20% by 
adjusting the number n of sub-compartments. The data for 0% TFE concentration have 
the longest lag phase (∼7 days) and the largest number of sub-compartments (n=4). 
Similarly, 10% TFE requires n=3, and 20% TFE which has the smallest lag phase and 
fastest fibril formation has n=1. Increasing the TFE concentration enhances α-helix 
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stability as seen in Table 1 of Fezoui and Teplow36 and Buck et al.85 Interestingly, the 
change in energy barrier heights causes an increase in the speed of the overall fibril 
formation process up to 20% TFE, but above this TFE concentration the increased 
stability of the α-helical structure acts as a kinetic trap and slows down the overall 
process. In addition to the TFE concentration dependence, the lag phase also depends 
on pH of the solution,65,14,28 and my model can be adapted to these biochemical 
environments as well. 
 
3.5 Discussion of Results 
It is important to note that though my results provide a good fit to a variety of 
experimental data analyzed in this paper, my model may need modification for other 
experimental conditions. Both the α-helix→β-structure sequence of steps as well as the 
possibility of a process involving α-helix→random coil→β-sheet are discussed in the 
literature.92,93 Velez-Vega and Escobedo94 discuss that the α-helix stage may be more 
important for some peptides than for others, while Soto et al.91 and Szabo et al.95 
discuss the possibility that the α-helix secondary structure is not necessary for 
fibrillogenesis. Additional pathways for aggregates are also proposed.96 My model can 
be appropriately modified to reflect different pathways. 
Important correlations can be made between my model and the kinetic model of 
fibril nucleation and elongation developed by Lomakin et al.2 In that work, one 
pathway for the fibrillogenesis mechanism for high protein concentration was described 
as: Monomers ←→ Micelles→Nuclei→Fibrils. The pathway of 
Monomers←→Micelles→Nuclei→Fibrils is dominant when protein concentration 
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exceeds a critical value above which pre-existing “seeds” are not necessary for fibril 
formation. Instead, high local protein concentration leads to formation of micelles that 
later form the domains of fibril nuclei. Experiments performed by Kirkitadze et al.28 
and Lomakin et al.2 exhibit similar lag times even though they were performed at 
different peptide concentrations, 25 µM and >100 µM, respectively. The similarity may 
be due to their peptide concentrations being above their respective critical micellar 
concentrations at which the lag times become independent of the peptide concentration 
as observed.2,97 Other experiments13,14,15 as well as the nucleation theoretical 
treatment98 show a more complicated dependence of aggregation rate and lag time on 
peptide concentrations. The Aβ monomers and the micelles were considered to be in 
rapid equilibrium so that this step was not the rate-limiting step. The two possible rate 
limiting steps in the model of Lomakin et al.2 are a micelle to nuclei formation process 
with a kinetic rate parameter they denoted as kn, and a fibril elongation process with 
rate parameter ke that incorporates free monomers that are present with concentration c. 
Different nuclei sizes have been reported for different conditions. For example, Pellarin 
and Calfisch99 found the sizes of the nuclei to vary between 4 and 18 monomers 
corresponding to different micellar oligomeric conditions. This number can be >30 
under certain conditions, as suggested by Garai et al.74 Here I use the nuclei size to 
have 10 monomers as considered by Lomakin et al.2 
The rate constant kn is the number of nuclei spontaneously formed out of 
micelles.2 By fitting the experimentally observed temporal evolution of the 
hydrodynamic radius of fibrils, Lomakin et al.2 estimated the value of kn to be 
2.4×10−6 s−1 or 0.207 d−1. Having kn be 0.207 d−1 represents one new nucleation every 
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five days per micelle. My rate limiting step in Fig. 3.1, used to generate the curves in 
Fig. 3.2 and Fig. 3.3, involves a similar structural transformation. In order to compare 
with my model, I convert kn in order to represent the number rate at which monomers 
contained in micelles transition to monomers contained in nuclei, rather than the 
number of micelles that transition to nuclei. Since each micelle on average has an 
aggregation number of 25 monomers, whereas there is an average number of 10 
monomers in a nucleus, I make the conversion as follows: kn=(0.207 nuclei 
micelles−1 d−1)×(10 monomers/nucleus)/(25 monomers/micelle)= 
0.207 d−1×(10/25)=0.083 d−1. The comparable step in my model corresponds to amino 
acid residues in βN species transforming into residues in βTX species, and the rate is 
represented by k3. Strikingly, the value of k3=0.039 d−1 (1.8×10−6 s−1) that I determined 
compares nicely (factor of 2) with Lomakin's value for kn. Also, my value for k3 falls 
nicely within the range of kn found experimentally by Wang et al.100 
The agreement between my k3 and the kn is further enhanced when we take into 
account that my value of k3 was determined by fitting to experimental data obtained at 
22 °C, whereas experiments2 for kn were performed at 25 °C. Since these reactions 
would likely occur faster27 at higher temperatures, we would expect my k3 to be larger 
if it was determined by analyzing experiments at higher temperature, if available. This 
would bring my k3 even closer to kn.  
My k3 and the nucleation rate kn refer to similar, but not identical processes. The 
observation that kn≥k3 is consistent with my proposed fibrillogenesis mechanism. The 
parameter kn refers to nucleation, whereas my k3 encompasses both nucleation and 
partial aggregation. Since nuclei must form before the formation of any toxic 
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protofibrils, the rate of nucleation kn can be expected to be faster than k3. Comparing 
my k3 to Lomakin’s kn directly connects Lomakin’s model using macroscopic structures 
such as micelles and nuclei to my model, which deals with kinetics of microscopic 
secondary structural elements. I would also like to compare my rate parameters with the 
rate parameter for elongation of ke.2 However, comparing my rate parameters with the 
rate parameter for elongation of ke is especially complicated and requires additional 
work since fibril formation in my model finishes with the step βTX→βM, but also 
includes a part of the βN→βTX conversion process. 
My model also allows for the calculation of the time-dependent increase in 
aggregate size. I now show that the calculated results agree well with experimental 
results, and allow differences in experimental conditions to be included in the 
calculations. Fig. 2 of Lomakin et al.3 shows the hydrodynamic radius as a function of 
time. Using formulas (1–3) from that reference, I can convert the hydrodynamic radius, 
Rh, for aggregates into the number of monomers n per aggregate: 
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where L is the length of an aggregate and λ is the number of monomers per unit length. 
I set λ equal to 1.6 as used in Lomakin et al.,3 Kusumoto et al.,101 and Tomski and 
Murphy.102 The other parameters are: n is the number of monomers per aggregate, and 
d is the diameter of an aggregate. I assume that all of the aggregates could be treated as 
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cylinders, as in Yong et al.103 which says that micelles have a spherocylindrical shape. I 
set d=8 nm for all the aggregates3,101 independent of L. I used Mathematica to invert 
equation (3.9) and find a value of L for each Rh in Lomakin et al.3 The L was then used 
to calculate n for each value of Rh. 
I calculate a theoretical curve from my model for the time evolution of the 
number of monomers per aggregate and compare with the experimental results of 
Lomakin et al.3 and Kusumoto et al.101 The two experiments were similar, but were 
done at different temperatures and this may have a significant effect on kn but not ke.27 
Though the steps in my model remain the same, differences in experimental conditions 
give different numerical values for the parameters in my model to fit each experiment. 
Differences in experimental conditions giving different numerical values for the 
parameters in my model is consistent with Lee104 in which it is reported that the average 
length of fibrils is sensitive to pressure and temperature. I define [βNT], [βTx], and [βM] 
as the percentages of the total number of monomers in non-toxic aggregates (micelles), 
toxic aggregates (nuclei), and mature aggregates, respectively. Similarly, mNT and mTx 
are the average numbers of monomers in a micelle and nucleus, respectively. Literature 
supports a micelle having 25 monomers on average and a nucleus having an average of 
10 monomers.2,3,99,27,103 I calculated the maximum number of monomers per aggregate, 
defined as parameter m⁎, which varies depending on the experimental conditions. The 
value of m⁎ is determined from the long-time, asymptotic value of the experimental 
data. The parameters aNT, aTx, and aM are the total numbers of non-toxic aggregates, 
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toxic aggregates, and mature aggregates, respectively, and N is the total number of 
monomers in the entire system. 
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Using eq. (3.15) I was able to obtain good fits to both sets of experimental data. 
The fit in Fig. 3.5a for the data from Lomakin et al.3 was done with [βNT] initially set at 
50%, [βTx] initially set at 50%, and [βM]=0. The parameter m⁎ used for this fit was set to 
340. This fit showed significant deviation from the data for small times. I will do 
further work to achieve a better fit. A fit was produced for the Kusumoto data using 
[βNT], [βTx], and [βM] all initially at 33.3% and m⁎ of 600. 
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Fig. 3.5 Theoretical fits (-------) to experimental data (□) for the number of monomers n 
per aggregate for two different experiments. (a) Lomakin et al.,3 (b) Kusumoto et al.101 
 
 One thing that is gained from Figure 3.5 is that for large times a state of 
equilibrium is reached in which the average size of aggregates is stabilized. Another 
thing learned from Figure 3.5 is the approximate number of proteins in a mature Aβ 
fibril. Since aggregates that are smaller than mature fibrils can be detected when it 
comes to getting the radius of hydration and some aggregates may never turn to mature 
fibrils, the average number of proteins in mature fibrils is likely to be larger than the 
asymptotic values in the two graphs in Figure 3.4. A question is why the asymptotic 
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value for the Figure 3.4b, about 600 proteins, is approximately twice the asymptotic 
value of the Figure 3.4a. Both experiments were done at similar experimental 
conditions and by the same group. Slight variations in experimental preparation 
procedures such as purification and synthesis may significantly change the peptide 
system’s fibrillogenic properties. A study showed that Aβ fibrils are composed of five 
or six protofilaments,9 whereas another study showed Aβ mature fibrils consist of two 
or three protofilaments.105 Experiments done by Pellarin showed mature fibrils having 
four protofilaments.106 
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4. RESULTS OF MD COMPUTER SIMULATIONS FOR PROTOFIBRILLAR 
FORMATION OF CCβ  
 In this chapter I provide results of my MD computer simulations that provide 
molecular details of the dynamics of protofibrillar formation by the peptide ccβ. I 
explain the steps that were taken to remove aphysical, computational artifacts so that 
the results would be physically valid. I also show how the MD results reinforce the idea 
that molecular heterogeneity is an important factor in understanding amyloid 
fibrillization.    
 
4.1 Computational Details   
 The initial configuration of the 12 chain system in my REMD simulation 
consisted of four ccβ coiled-coil α-helix trimers arranged at the corners of a square, as 
shown in the first panel of Figure 4.1. Each trimer was created from the coordinates in 
the PDB 1S9Z file. The PDB file contains the atomic coordinates for a single ccβ helix 
along with the translation and rotation coordinates for adding two additional ccβ 
peptides to form a triplet. The four trimers at the corners of a square were separated by 
enough distance to ensure that there would be no van der Waals overlap between atoms 
from different trimers, with at least 24 Å between the center of mass of one trimer and 
the center of mass of another trimer. The EEF1 force field with implicit solvent was 
used for modeling the solvation.   
 I performed the REMD simulation for 300 ns using 20 replicas with exponential 
spacing of the temperatures in a range of 380K-600K: 380.00K, 389.25K, 398.72K, 
408.42K, 418.36K, 428.53K, 438.96K, 449.64K, 460.58K, 471.79K, 483.27K, 
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495.03K, 507.07K, 519.41K, 532.05K, 544.99K, 558.25K, 571.83K, 585.75K, 
600.00K. Each MD step was 2fs and I saved the configuration every 500 steps (making 
each frame 1ps apart). My temperature swap test was performed every 500 MD steps. I 
performed 20 ps of REMD initialization and 20 ps of REMD equilibration. The average 
acceptance rate for temperature swapping was 24%, which is close to the ideal of 
20%.107,108 
 In addition, I performed MD simulations at a constant temperature (CTMD). The 
parameters were the same in the CTMD as in the REMD simulations, except for the 
temperature. Also, in some of the CTMD simulations, there was a DROFF (confining 
potential radius) of 100Å as opposed to 600Å in the REMD simulations.  
 
4.2 Description of β-Sheet (Nucleus) Formation 
 Figure 4.1 shows a sequence of frames taken at various times for a replica that 
formed two β-sheets, an important structural stage for the eventual fibrillization that 
could occur in a much larger system than I investigated. During the 300 ns covered in 
this simulation, this replica changed its temperature many times. 
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Fig. 4.1 Frames from the REMD simulations showing steps in the helix structural 
transition to β-strands and the formation of β-sheets. 
 
 My REMD simulation was performed in a temperature range from 380K to 600K 
in order to investigate β-chain formation and aggregation. These relatively high 
temperatures cause the initial α-helical trimers to rapidly unfold so that the system 
quickly progresses to the random coil/β-hairpin/β-aggregate stages that I am interested 
in investigating. Experimental observations on ccβ found that at 310K, the α-helical 
configuration is unstable.42 Consistent with this, all of my replicas lost their initial α-
helical conformations within 1 ns. I focus attention on one replica, replica 3, which 
created the structure that most resembles a protofilament. The process of fibrillation for 
replica 3 is summarized in Figure 4.1. The last frame in Fig. 4.1 (from replica 3) looks 
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like a protofilament steric zipper. It has similarities to the transthyretin single protein.109 
For amyloids in general, some aggregates have parallel β-sheets, some have antiparallel 
β-sheets,110 and some have both parallel and antiparallel β-sheets.111,112  
 For the replicas that created a β-aggregate, after the proteins get out of the α-helix 
secondary structure, some of the segments of the chain are in random coil and some are 
in β-structure. The proteins associate with each other in a disorganized aggregate, like a 
micelle. They then reorganize to form the β-aggregate.  
 To quantify the organization of the last frame of replica 3 (t-300 ns), which is 
shown in Figure 4.1, I calculated the nematic order parameter S for the larger of the two 
β-sheets, which contains six ccβ chains. The nematic order parameter113 is a measure of 
the alignment of rods in a system. I set S to be the largest eigenvalue of the matrix 
 𝑄!" = !!!"#$%&' !! 𝑎!"𝑎!" − !! 𝛿!"!!"#$%&'!!!    (4.1) 
 
where j is an index that identifies each rod, α and β represent laboratory Cartesian 
coordinates, and 𝑎! is the unit direction vector for rod j. In my ccβ system, the protein 
chains are not perfectly rigid rods. I chose the direction vector, 𝑎! for each protein to be 
the principal axis of the Cα inertia tensor 𝐼!" = 𝑚! 𝑟!!𝛿!" − 𝑟!"𝑟!"!!"#$%!!!  
corresponding to the smallest value of the moment of inertia for that chain. This 
provides a direction that is an average for the Cα atoms in the chain. ri is the distance 
from the center of mass of the protein to each of the middle eleven Cα atoms in the 
protein. I used only the middle eleven of the 17 residues because a β-strand protein, 
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even when attached to other proteins, often has considerable flexibility for the amino 
acids near either end. Figure 4.2 shows for replica 3 the nematic order parameter as a 
function of time for the proteins that make up the largest β-sheet. A nematic order 
parameter of one means that there is perfect alignment of the protein direction vectors 
and zero means total isotropy in the arrangement of the protein direction vectors. 
Characteristic structures for the six chains are also displayed at various times during the 
simulation. Since these results are from an REMD simulation, a single replica such as 
replica 3 changes temperature often. The temperature of replica 3 at any time is shown 
by the color of the curve. The order of colors from high temperature to low temperature 
is: redàyellowàgreenàcyanàblue.   
 
Figure 4.2 The nematic order parameter S for the proteins that make up the largest β-
sheet in replica 3. Characteristic structures for the six chains are displayed at various 
times during the simulation. The temperature of replica 3 at any time is shown by the 
color of the curve. The order of colors from high temperature to low temperature is: 
redàyellowàgreenàcyanàblue.   
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 Figure 4.2 displays large changes in S during the first 40 ns while the six β-
strands undergo major rearrangements relative to each other. By 50 ns, the six chains 
have settled into a low energy, stable steric zipper β-sheet configuration with much 
smaller fluctuations in S. In the β-sheets formed in the simulations, each β-strand has a 
twist. The average twist angle for the larger of the two β-sheets for the last 200 ns is 
10°. This is a similar twist angle to that calculated in Knowles et al.114  
 
4.3 Phase Transition 
 Experimental observations42 find that at a temperature of 277K, ccβ exists as a 
stable coiled-coil α-helix trimer, whereas at 310K the helical structure converts to β-
strands. REMD investigations on a single trimer by Strodel et al.40 found that a β-sheet 
composed of three ccβ chains is stable up to a temperature of 440K. 
In order to investigate the thermodynamics of the process, I calculated various 
parameters from my REMD simulations. Figure 4.3 displays the heat capacity as a 
function of temperature for my system of 12 chains. The heat capacity at each 
temperature was calculated from the fluctuations in the energy using equation (4.2) 
 
   (4.2) 
 
I found that for all temperatures, the system had settled into its final configuration, 
whether ordered into an aggregate or not, by 100 ns. Therefore, I calculated the 
2
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=
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equilibrium CV at all temperatures using the final 200 ns of the simulations, which 
covers the period from 100 ns to 300 ns. 
 
Figure 4.3 The heat capacity of my 12 chain system as a function of temperature. 
 
The process in my system fits the thermodynamic characteristics of a phase 
transition, as can be seen by the peak in the heat capacity curve at the temperature point 
507K. In order to obtain more information on the dynamics that produce this heat 
capacity peak, I calculated additional parameters. The criterion to determine if two 
chains are a part of the same aggregate is if the center of mass of any residue of one 
chain is within a certain distance of the center of mass of any residue of the other chain. 
This distance is 1/2(dres1+dres2), in which dres=3.5Å+2*|RCα-RCOM|. RCα and RCOM are 
the positions of the Carbon α atom and the center of mass of the residue respectively. 
The reason for the 3.5Å in the formula for dres is if the Carbon α atom and the center of 
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mass of the residue have the same position. 3.5Å is the distance between two covalently 
bonded Carbon atoms. Figure 4.4 displays the number of chains in the largest aggregate 
as a function of temperature, averaged over the last 200 ns. It is clear from Figure 4.4 
that significant aggregation occurs only for temperatures below 500K. 
 
Figure 4.4 The number of chains in the largest aggregate as a function of temperature, 
averaged over the last 200 ns. 
 
4.4 Validity of Results  
I examined the two β-sheet structure formed in replica 3. This type of structure 
may be important in allowing ccβ to form amyloid-like protofilaments. As can be seen 
in Figure 4.5a, the two β-sheets are held together by a variety of sidechain interactions. 
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The blue (positively charged arginine) and red (negatively charged glutamic acid) 
sidechains are oppositely charged sidechains which provide electrostatic forces between 
the β sheets. Figure 4.5b shows that similar sidechains extend out on both sides of each 
sheet, providing the ability for additional sheets to be added to increase the size of the β 
aggregate. Each sheet also contains white spheres representing hydrophobic sidechains 
(isoleucine and leucine) on each side, both in the middle between the two sheets (Figure 
4.5a) and on the outside (Figure 4.5b). The specific location of these hydrophobic 
regions may provide specificity that directs the proper alignment115 of sheets as they are 
added to the aggregate. 
I found that ccβ formed β-sheets that are held together by electrostatic forces 
between charged sidechains. Charged sidechains are located on both sides of each β-
sheet, providing the opportunity for additional β-sheets to be added in layers to increase 
the size of the aggregate. Regions of hydrophobic sidechains may provide specificity 
that facilitates alignment of charged sidechains as the β-aggregate grows in size 
.  
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Figure 4.5 From replica 3, positively charged (blue) and negatively charged (red) 
sidechains provide strong binding interactions: (a) between two β-sheets to hold the 
sheets together (b) on the outside of the two β-sheets to allow the addition of more β-
sheets to the aggregate. Hydrophobic sidechains (white spheres) may provide 
specificity to facilitate alignment. 
 
 In addition to determining the average number of chains in the largest aggregate, I 
also investigated the amount of order or stability in the size of the largest aggregate. In 
Figure 4.6 I plot the normalized number fluctuations χn for the chains in the largest 
aggregate 
 𝜒! = !!!!!!!!!!!!!    (4.3) 
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Figure 4.6 Stability of the largest aggregate based upon a parameter χn that measures 
the fluctuations in the number of chains in the largest aggregate. 
 
Even though there are a much larger number of chains in the largest aggregate 
for temperatures below 500K compared to temperatures above 500K, Fig. 4.6 shows 
that below 500K the structure of the system is much more stable with very small 
fluctuations. The isothermal compressibility can be calculated using the expression35 𝜅! = 𝜒! 𝑉 𝐾𝑇 . Figure 4.6 for χn shows that the structurally organized aggregate 
below 500K has a significantly smaller κT compared to the disorganized system above 
500K, which makes physical sense. Experimenal determination of κT is a possibilty for 
validating my results.  
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4.5 Temperature Window of β-Sheet Formation 
The figures shown above reflect properties of the multichain system and 
interactions between the chains. I also investigated the behavior and dynamics of 
individual chains within the system.  
Hydrogen bond rearrangement is an important factor accompanying the 
structural transition from α helix to β sheets. At all of the temperatures that I used in the 
simulations, the α helices fall apart too quickly (< 1 ns) for me to monitor them and 
their intra helix hydrogen bonds. However, I was able to monitor the formation of 
interchain hydrogen bonds as β strands form and aggregate into β sheets. Figure 4.7 
shows the time development of interchain hydrogen bonds for different temperatures. 
Since these results are from REMD simulations, the characteristic times are not 
reliable. However, the plots show that below 507K, the number of interchain hydrogen 
bonds increases as the replicas form a β sheet, whereas above 507K the number of 
interchain hydrogen bonds never stabilizes at a high number, implying that a β sheet 
never forms. 
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Fig 4.7 Number of interchain hydrogen bonds versus time. (a) 380K (b) 472K (c) 507K 
(d) 600K. 
 
In order to better understand the role of hydrogen bonds in the structural 
transition, I examined how the number of hydrogen bonds varied depended on 
temperature at the end of my simulations.  Figure 4.8 displays the number of interchain 
hydrogen bonds, as well as the number of intrachain hydrogen bonds, averaged over the 
final 200 ns. It can be seen that the number of interchain hydrogen bonds drops 
suddenly to almost zero above 500K, which matches the temperature dependence 
displayed in Figure 4.4 for the number of chains in the largest aggregate. In contrast, 
the number of intrachain bonds begins to drop at a temperature of 450K, a lower 
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temperature than the dramatic drop that occurs for the interchain hydrogen bonds at 
500K. 
 
Figure 4.8 Average number of hydrogen bonds as a function of temperature. Top: 
interchain hydrogen bonds, Bottom: intrachain hydrogen bonds. 
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Figure 4.9 The average number of chains that are in a hairpin structure as a function of 
temperature. 
 
 The graphs above that reflect the behavior of the multichain system show a clear 
structural transition involving β-structure that occurs around 500K (Figure 4.3). Above 
500K, the system is highly disordered with negligible aggregation (Figure 4.4) and 
large fluctuations (Figure 4.6). Below 500K there is almost complete aggregation of all 
β-chains into stable aggregates with little fluctuation.  
 In my REMD simulation, if the system does not spend significant time above 
450K, the individual chains remain in β-hairpin conformation and form non-amyloid 
structures. However, if the system spends significant time above 450K, Figure 4.9 
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shows that the probability for an individual chain to be in a hairpin structure drops 
significantly. This allows individual chains to straighten-out into β-strands, a process 
that is facilitated by hairpin structures forming hydrogen bonds with other chains. The 
straightened β-strands are in a conformation that allows them to bind into β-sheets and 
form protofibrils. However, Figure 4.8 shows that above 500K, the probability for 
forming the interchain hydrogen bonds necessary to form β-sheets drops dramatically. 
As shown in Figure 4.4, this prevents the formation of aggregates above 500K. 
The CTMD simulations showed that there tends to be hairpins at low 
temperatures and straightened-out chains at high temperatures.  
To better understand the relevance of interchain and intrachain hydrogen bonds 
on the structure of individual protein chains, I determined the average number of chains 
that are in a hairpin structure as a function of temperature. This is plotted in Figure 4.9. 
A chain was counted as being in a hairpin configuration if it contained four or more 
intrachain hydrogen bonds. The drop in Figure 4.9 above 450K closely matches the 
temperature dependence of the number of intrachain bonds displayed in Figure 4.8.  
In general for amyloid proteins, the intermediate aggregates are composed of β-
strands in the hairpin state along with β-strands that are extended. The smaller 
oligomers tend to have a higher percentage of β-strands in the hairpin state than the 
mature fibrils. Hairpins seem more likely to straighten out as an aggregate gets bigger26 
because there are more interactions between chains that can dominate over the 
intrachain hydrophobic interactions that stabilize the hairpin conformation of a chain. 
However, even in large β-sheets, proteins in a hairpin conformation can serve as the 
growing end of the sheet.26,22,116,117 
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 Two different structural transition processes involving hydrogen bonds are 
required for aggregation into fibrils: the breaking of intrachain hydrogen bonds to allow 
β-hairpin proteins to straighten, and the subsequent formation of interchain hydrogen 
bonds during β aggregation into amyloid fibrils. For my REMD investigations, I found 
that the temperature dependence of these two different β structural transition processes 
results in the existence of a temperature window that the protein experiences during the 
process of forming protofibrillar structures. Appearance of the temperature window 
allows me to investigate the dynamics on a molecular level. If the protein system in my 
simulations spends all of its time at either lower temperatures or higher temperatures 
relative to this window, fibrillization will not occur.  
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4.6 Free Energy and Heterogeneity 
 
Figure 4.10 Free energy at 380K for all 300ns (minus 20 ps from initialization and 20 
ps from equilibration). The end to end distance(dee) is the distance, averaged over all 12 
proteins, from the Cα at one end to the Cα at the other end of the protein.   
 
The free energy for 380K for the last 300 ns (minus 20 ps from initialization and 
20 ps from equilibration) is shown in Figure 4.10. The reason I included the free energy 
for the entire simulation is to include the structures going from a disordered aggregate 
to an ordered β-aggregate. The free energy was calculated by first creating bins. Each 
bin included a range of nematic order parameter values and a range of dee values. For 
each bin, the number of frames within the S and dee ranges of that bin for a certain 
temperature (for whatever replica at the frame that fits the criteria) was counted. The 
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formula for the free energy, G=-RTln(P), was used, with P the fraction of frames that 
are within a certain bin. 
The graph in Figure 4.10 shows that there is a lot of heterogeneity for the earlier 
structures as well as for the β-aggregates that form later in the simulation. There are 
many places of dark blue, and each dark blue island can have many significantly 
different structures. The structure of the system is not defined totally by dee and S.  
 
Figure 4.11 Free energy at 507K as a function of dee and S for the last 200 ns. 
 
The free energy in Figure 4.11 is at the temperature 507K. (The transition 
temperature 500K was not one of the specific temperatures in my REMD simulation.) 
There is only one free energy well. If this was a first-order transition, there would likely 
be two free energy wells at the transition temperature. According to polymer theory, a 
first-order phase transition happens for a homogenous polymerizing system.118 
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However, a glass-like transition happens for a polymerizing system that is 
heterogenous.118 A glass-like transition is a continuous transition.118 It has similarities 
to a second-order phase transition, but is not strictly a second-order phase transition.118  
The last frame of replica 3 is shown as the last panel of in Figure 4.1. The last 
frame in replica 3 looks more like a steric protofilament than the last frame of any of 
the other replicas. Replicas 14 and 16 also look like steric zipper protofilaments. 
However, you can see large structural differences among replica 3, 14, and 16. Figure 
4.12 shows the last frame of replicas 3, 14, and 16 next to each other. 
 
Figure 4.12 Last frame of replicas 3, 14, and 16 next to each other. 
 
4.7 Protein to Protein Interactions 
The CTMD showed that the fibril formation occurs much quicker with a smaller 
confining potential radius as opposed to a larger confining potential radius. With a 
smaller confining potential radius, there is more protein to protein contact and hence 
more chance for proteins to catalyze each other to change other proteins’ secondary 
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structure. Increasing the concentration in amyloid structures has the effect of speeding 
up the aggregation process. 
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5. CONCLUSIONS 
To investigate the kinetics and thermodynamics of amyloid formation in 
amyloidogenic proteins, I used various mathematical and computational tools. 
Specifically, I developed a mathematical model to investigate the population kinetics of 
structural conversions leading to Aβ fibril formation. I then used molecular dynamics 
(MD) computational simulations to investigate the molecular details of the structural 
transformations and calculate thermodynamic parameters for amyloid formation. I 
employed a special form of molecular dynamics, Replica Exchange Molecular 
Dynamics (REMD), which is described in section 2.2.5, to simulate a system of 12 ccβ 
proteins. I found that the results of both the mathematical modeling of the kinetics and 
the molecular dynamics computational simulations could be explained in terms of two 
important molecular-level aspects. Section 5.1 emphasizes how hydrogen bond 
rearrangements correlate to aggregation phase transitions and population dynamics of 
secondary structure. In section 5.2 I describe how my results show the prevalence of the 
heterogeneity in the systems I studied. Section 5.3 discusses more ideas for MD 
simulations and suggests experimental ideas based on my results. 
 
5.1 Hydrogen Bonds 
The model I developed to fit the population of secondary structure kinetics data 
that was available from experiments is described in Fig. 3.1 and Table 3.1. For my 
fitting of the Kirkitadze data28, Fig. 3.2, I fit changes of secondary structure with time. 
Changes in secondary structure with time correlate with changes in the number of 
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interchain and intrachain hydrogen bonds. α helices have a lot of intrachain hydrogen 
bonds, whereas β-sheets have a lot of interchain hydrogen bonds.  
Two different structural transition processes involving hydrogen bonds are 
required for aggregation into fibrils: the breaking of intrachain hydrogen bonds to allow 
hairpin proteins to straighten, and the subsequent formation of interchain hydrogen 
bonds during β aggregation into amyloid fibrils. For my REMD investigations, I found 
that the temperature dependence of these two different β structural transition processes 
results in the existence of a temperature window that my system experiences during the 
process of forming protofibrillar structures. If a replica in my simulation spends all of 
its time at either lower temperatures or higher temperatures relative to the temperature 
window, fibrillization will not occur. 
My MD simulations look at molecular-level details of some of the stages whose 
transition kinetics I mathematically modeled. A summary of the steps from the MD 
simulations of the ccβ replica that created the aggregate that most resembled a steric 
zipper protofilament is shown in Figure 4.1.  
In Figure 4.7, the number of interchain hydrogen bonds versus time for four 
different temperatures is displayed. For the temperatures 380K and 472K, the number 
of interchain bonds increases as time advances. The reason for the increase in the 
number of interchain hydrogen bonds is the formation of β-sheets. For temperature 
507K, the number of interchain hydrogen bonds fluctuates rapidly. The reason for the 
rapid fluctuation is that this is the transition temperature, in which some replicas form 
β-sheets and some don’t. At 600K, there are few interchain hydrogen bonds throughout 
the simulation, since the temperature is too high to allow β-sheets. 
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I found that the hydrogen bond rearrangement is an important factor in the 
structural transition and helps elucidate the temperature dependency. The initial 
configuration of the 12 chains was all α-helix, which means many intrachain hydrogen 
bonds. At all temperatures, the α helices fell apart too quickly (<1 ns) for me to be able 
to monitor the helical intrachain hydrogen bonds. I was able to monitor the increase of 
interchain hydrogen bonds as β sheets form, as shown in Figure 4.7. Since my 
simulations used REMD, the time scales in Fig. 4.7 are not reliable, but the temperature 
dependencies are. I examined the temperature dependencies more carefully. Figure 4.8 
displays the number of interchain hydrogen bonds, as well as the number of intrachain 
hydrogen bonds, averaged over the final 200 ns. It can be seen that the number of 
interchain hydrogen bonds drops suddenly to almost zero above 500K, which matches 
the temperature dependence displayed in Figure 4.4 for the number of chains in the 
largest aggregate. In contrast, the number of intrachain hydrogen bonds begins to drop 
at a temperature of 450K, a lower temperature than the dramatic drop that occurs for 
the interchain hydrogen bonds at 500K.  
At high temperature the system being entropically favored makes it so that 
random coils are the preferred secondary structure. Hydrogen bonds don’t last long in 
proteins in random coil because each protein can sample many different configurations. 
At low temperature the system being enthalpically favored makes the proteins have 
many hydrogen bonds. The proteins having many hydrogen bonds lowers the energy, 
but also makes it a low entropy configuration.   
The graphs that reflect the behavior of the multichain system show a clear 
structural transition involving β-structure that occurs around 500K (Figure 4.3). Above 
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500K, the preferred configuration of the system is highly disordered with negligible 
aggregation (Figure 4.4) and large fluctuations (Figure 4.6). Below 500K there is 
almost complete aggregation of all β-chains into stable aggregates with little 
fluctuation.  
 Interestingly, my REMD simulation displayed dynamics defined by a temperature 
window for the formation of organized β-sheets in the region of 450K to 500K. If the 
system does not spend significant time above 450K, the individual chains remain in 
hairpin conformation and form non-amyloid structures. If the system spends significant 
time above 450K, Figure 4.9 shows that the probability for an individual chain to be in 
a hairpin structure drops significantly. This allows individual chains to straighten-out 
into β-strands, a process that is facilitated by hairpin structures forming hydrogen bonds 
with other chains. The straightened β-strands are in a conformation that allows them to 
form interchain hydrogen bonds and organize into β-sheets that can form protofibrils. 
However, Fig. 4.8 shows that above 500K, the probability for forming the interchain 
hydrogen bonds necessary to form β-sheets drops dramatically. As shown in Fig. 4.4, 
this prevents the formation of any type of aggregate above 500K. 
To better understand the relevance of interchain and intrachain hydrogen bonds 
on the structure of individual protein chains, I investigated more closely the hairpin 
intermediate conformation that prevents chains from organizing into β-sheets. I 
determined the average number of chains that are individually in a hairpin structure as a 
function of temperature. This is plotted in Fig. 4.9. A chain was counted as being in a 
hairpin configuration if it contained four or more intrachain hydrogen bonds. The drop 
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in Fig. 4.9 above 450K closely matches the temperature dependence of the number of 
intrachain bonds displayed in Fig. 4.8.  
 
5.2 Heterogeneity 
The ccβ protein system I simulated had 12 chains, each with 17 amino acid 
residues. Based on simulations performed by other researchers of two short Aβ(16-22) 
peptides that showed significant heterogeneity in forming dimers18 we can expect 
significantly more heterogeneity in my system of ccβ aggregation. The reasons for the 
greater heterogeneity are that my system has more chains and each ccβ chain is longer 
than each Aβ(16-22) peptide. We can expect even more heterogeneity in systems of 
Kirkitadze et al.28 and Walsh et al.37, having a large number of Aβ(1-40) proteins.  
The mathematical model I used to fit population dynamics of secondary 
structure is shown in Figure 3.1. To represent the heterogeneity in the system, in the 
mathemaitcal model I used sub-compartments which are mathematically equivalent to 
heterogeneous distributions.  My fit to the kinetic data in the article by Kirkitadze28, Fig 
3.2, had four sub-compartments which shows a significant amount of heterogeneity. I 
spent a lot of time working to get the parameters just right for the best fit, including the 
number of sub-compartments. The more sub-compartments, the more heterogeneity.77 
The shapes in the population dynamics curves are significantly different with four sub-
compartments than with no sub-compartments, as shown in Figure 3.15 of in the book 
Modeling Infectious Diseases in Humans and Animlas by Keeling.77 My fitting to the 
data from the Walsh article37, Fig 3.3a, had six sub-compartments, displaying even 
more heterogeneity than in the data from the Kirkitadze article.28  
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In addition to the heterogeneity in my modeling of the kinetics, my MD 
simulations also manifested significant heterogeneity. From the MD results, I 
calculated the free energy of various configurations of the 12 chain system. The amount 
of heterogeneity in my ccβ simulations can be seen in the free energy plot for a 
temperature of 380K, Figure 4.10. There are a many different regions on the free 
energy plot that have low free energy. In addition, each region of low free energy on 
that diagram contains different structures.   
  According to polymer theory, a first-order phase transition can occur in a 
homogenous polymerizing system.118 However, a glass-like transition happens for a 
polymerizing system that is heterogenous.118 A glass-like transition is a continuous 
transition.118 It has similarities to a second-order phase transition, but is not strictly a 
second-order phase transition.118 There weren’t enough data points in the heat capacity 
curve, Figure 4.3, to decide whether it was a first-order phase transition. However, I 
deduced from the free energy diagram at the transition temperature, 507K, Figure 4.11 
that my system did not display a first-order phase-transition. There is only one free 
energy well that spans the different large-scale configurations, showing a continuous 
phase transition.  
 The heterogeneity in my REMD simulations was also shown by the different 
replicas. Not all replicas formed β-aggregates. Those replicas that produced β-
aggregates all produced a different β-aggregate or β-aggregates. The last frame of the 
three replicas that most resembled steric zipper protofilaments are shown in Figure 
4.12. They look significantly different from each other.  
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 Figure 4.2 shows the nematic order parameter S for the proteins that make up the 
largest β-sheet for the replica that most resembled a steric zipper protofilament. A value 
of one for S means there is perfect alignment of all the protein direction vectors and 
zero means total isotropy in the protein direction vectors. Figure 4.2 displays large 
changes in S during the first 40 ns while the six β-strands undergo major 
rearrangements relative to each other. This shows a lot of heterogeneity in the early 
micelle-like aggregates. 
 
5.3 Directions for Future Work 
 If I had more time, I would have wanted to do simulated annealing constant 
temperature MD to help verify the temperature window hypothesized from my REMD 
simulation. The procedure for simulated annealing constant temperature MD is as 
follows: (1) perform constant temperature MD with the system of 12 ccβ proteins at 
600K for 15ns; (2) take the last frame of the simulation at 600K and use it for another 
constant temperature simulation at 590K for 15ns; (3) take the last frame of the 
simulation at 590K and use it for the first frame of a simulation at 580K; (4) continue 
this process down to 380K. 
 Other simulations of ccβ would be around 20 different 150 ns constant 
temperature MD simulations of my ccβ system at the same temperature and other 
conditions. As mentioned in Chapter 4, 100 ns is about the time it takes a system to 
equilibrate. Because MD has some random numbers in it, each simulation is likely to 
create unique structures and dynamics for each simulation, even though they all would 
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have the same conditions. Seeing how different each simulation is from the other ones 
will help to understand how heterogenous the aggregation process is.   
 Both KFFEAAAKKFFE and KFFEYNGKKFFE have four amno acids flanked 
on both sides by the de novo peptide KFFE. KFFEAAAKKFFE does a better job of 
forming amyloid fibrils than KFFEYNGKKFFE.119 KFFEYNGKKFFE folds into a 
stable β-hairpin.119 MD simulations on a system of several KFFEYNGKKFFE peptides 
and on a system of several KFFEAAAKKFFE peptides could help investigate why 
KFFEYNGKKFFE has a higher propensity than KFFEAAAKKFFE to form β-hairpins. 
For ccβ, temperature is the control parameter for its structural transitions. One 
idea for experiments on ccβ is to have the experiment start with high temperature and 
slowly lower the temperature. This change in the temperature during the experiment 
can help facilitate the process of fibrillization.  
For the REMD simulations on ccβ, I found hydrogen bonds between backbone 
atoms. This made my results generalizable to any protein because every protein has the 
same backbone. The two different structural transitions involving hydrogen bonds that 
are controlled by temperature in ccβ may also create a window for other amyloid 
forming proteins, but the window-defining control parameter may not be temperature. 
For other amyloid forming proteins in which temperature is not the structural transition 
control parameter, perhaps another control parameter may be used based on the 
knowledge gained from the current work on ccβ for which there is a temperature 
window.  
  Figure 3.4 helps explain the energetics of how Trifluoroethanol (TFE) affects the 
secondary structure. Intermolecular bonds are formed at low TFE concentrations, 
 98 
whereas, at high TFE concentrations, intramolecular hydrogen bonds are preferred.85 
The temperature window found for ccβ can help explain why too much TFE for Aβ 
mentioned in section 3.4.1 impedes fibrillization. A condition is necessary in which 
there can be breaking of intrachain hydrogen bonds, not only for the α helices to break 
once they’ve formed but also for the hairpins to straighten out.  
One idea is to experimentally start out with a high concentration of TFE for Aβ. 
This can stabilize the α helices. Then the experimentalist can lower the concentration of 
TFE after many α helices have been formed. Lowering the concentration of TFE helps 
not only the α helices to break but also helps straighten out the β-strands.     
 An idea for therapies to prevent amyloid diseases is to stabilize the proteins in 
their hairpin state. One idea for a control parameter to be put into medications are 
affibodies.120,121 Affibodies are binding proteins derived from the Z domain of 
staphylococcal protein A.121 Affibodies are able to stabilize the hairpin state of proteins 
by clamping down on them.122 
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